Copenhagen DenmarkAbacus Medicine provides pharmaceutical products for pharmacies, hospitals, wholesale customers and clinical trials.

Orient Plads 1, 1. Nordhavn, Copenhagen, 2150 DenmarkAbzu® has developed a proprietary, explainable AI and applies it to a range of applications in the life sciences. Our specialist teams apply our pioneering technology, the QLattice®, to find highly predictive and explainable machine-learning models. Applications include 1) modelling and design of RNA therapeutics 2) modelling and design of therapeutic peptides and 3) building simple and highly predictive biomarker signatures from high-dimensional clinical data Founded in January 2018, Abzu is a deep tech startup with offices in Copenhagen, Denmark and Barcelona, Spain.

aCROnordic A/S, Scion DTU, Kogle Allé 5 DK-2970 Hørsholm, DenmarkaCROnordic provides clinical operations, development consulting, regulatory affairs, and quality assurance.

Hørsholm, 2970 DenmarkaCROnordic provides clinical operations, development consulting, regulatory affairs, and quality assurance.

Lund, Skåne County SwedenActive Biotech offers in vitro ADME, pharmacokinetics and metabolism study services.

Scheelevägen 22, P.O. Box 724, SE-220 07 Lund, SwedenActive Biotech offers in vitro ADME, pharmacokinetics and metabolism study services.

Copenhagen DenmarkAGA Gas provides industrial gas.

Lottenborgvej 26 Lyngby, DK-2800 Kgs DenmarkAlbumedix develops albumin-based products and technologies for advanced drug and vaccine formulation, extended drug half-life and improved drug delivery. Our products and technologies are used in clinical and marketed drugs and out-licensed to pharmaceutical and biotech companies worldwide. With over 25 years’ experience in the biopharmaceutical industry, we have the scientific, technical and regulatory expertise needed to support companies in moving faster to market with superior biotherapeutics. We also use this expertise to strengthen our own drug pipeline. Albumedix is a global company and a fully owned subsidiary of Novozymes A/S Our brand promise The Albumedix brand encapsulates the values by which we work, as well as the past and future of our company. Our logo depicts the heart-shaped albumin molecule in a soft-edged hexagon ring, recognizable as a benzene ring arrangement, it balances both our ambition and promise of creating superior biotherapeutics for improved patient outcomes. The heart-shape represents the symbolic way albumin is illustrated today, while also reminding us of the many important ways by which it helps improve lives.

Rudeboksvägen 1 Lund, SE-226 55 SwedenAlfa Laval specializes in heat transfer, separation, and fluid handling.

ALK-Abelló A/S Bøge Alle 6-8 Hørsholm DK-2970 DenmarkALK offers allergy vaccines, emergency treatment, and allergy diagnostics.

Copenhagen Europe Centre Building 12, 5th floor Vesterbrogade 149 DK-1620 Copenhagen DENMARKAlkalon specialzies in the development of medicated chewing gum formulations and offers contract research and product development.

Scheelevägen 19 A 223 70 Lund SwedenAlligator Bioscience is a research based biotech company focused on the development of drugs for cancer and inflammation.

Lyngby Storcenter 66, lejl. 1203 DK-2800 Kongens Lyngby DenmarkAppliChem offers custom synthesis, cell culture media, reagent products and services.

Ideon Science Park, Lund SwedenAstrom Research provides clinical trial reporting and regulatory services in China.

Agern Alle 1 Hørsholm, DK-2970 DenmarkBavarian Nordic focuses on developing product candidates to address cancer and infectious diseases by leveraging several core strengths: Revenue generating; consistent break even results Fully integrated R&D & manufacturing Two major pharma collaborations Differentiated pipeline in infectious diseases and oncology Approved discovery platform Through long-standing collaborations, including a collaboration with the U.S. government, Bavarian Nordic has developed a portfolio of vaccines for infectious diseases, including the non-replicating smallpox vaccine, IMVAMUNE®, which is stockpiled for emergency use by the United States and other governments. The vaccine is approved in the European Union (under the trade name IMVANEX®) and in Canada. Bavarian Nordic and its partner Janssen are developing an Ebola vaccine regimen, which has been fast-tracked, with the backing of worldwide health authorities, and a vaccine for the prevention and treatment of HPV. Additionally, in collaboration with the National Cancer Institute, Bavarian Nordic has developed a portfolio of active cancer immunotherapies, including PROSTVAC®, which is currently in Phase 3 clinical development for the treatment of advanced prostate cancer. The company has partnered with Bristol-Myers Squibb for the potential commercialization of PROSTVAC.

Agern Alle 1 DK-2970 Hørsholm DenmarkBavarian Nordic focuses on developing product candidates to address cancer and infectious diseases by leveraging several core strengths: Revenue generating; consistent break even results Fully integrated R&D & manufacturing Two major pharma collaborations Differentiated pipeline in infectious diseases and oncology Approved discovery platform Through long-standing collaborations, including a collaboration with the U.S. government, Bavarian Nordic has developed a portfolio of vaccines for infectious diseases, including the non-replicating smallpox vaccine, IMVAMUNE®, which is stockpiled for emergency use by the United States and other governments. The vaccine is approved in the European Union (under the trade name IMVANEX®) and in Canada. Bavarian Nordic and its partner Janssen are developing an Ebola vaccine regimen, which has been fast-tracked, with the backing of worldwide health authorities, and a vaccine for the prevention and treatment of HPV. Additionally, in collaboration with the National Cancer Institute, Bavarian Nordic has developed a portfolio of active cancer immunotherapies, including PROSTVAC®, which is currently in Phase 3 clinical development for the treatment of advanced prostate cancer. The company has partnered with Bristol-Myers Squibb for the potential commercialization of PROSTVAC.

Bogbinderivej 6 DK-3390 Hundested DenmarkBifodan is a specialized provider of innovative probiotic solutions to the pharmaceutical and dietary supplement industries.

21 Lyshøjvej Ølstykke, 3650 DenmarkBioAdvice is a GLP and GMP compliant preclinical Contract Research Organisation (CRO) located in Denmark. BioAdvice is part of Minerva Imaging and provides services within multiple areas of preclinical in vivo drug testing, with emphasis on metabolism, inflammation and dermatology. We have specialized within pharmacokinetic (PK) and pharmacodynamic (PD) studies in multiple species incl. mice, rats, dogs, minipigs and slaughter pigs. Our services also include work on microbiome/challenge studies, medical device testing in large animals and GMP batch release testing. The laboratories and animal facilities are approved to work with BSL2 and GMO 1 organisms, and includes in vivo imaging capabilities.

Malmö, Skåne County SwedenBioglan offers development and manufacturing of semi-solid and liquid products for pharmaceutical, healthcare and life science companies.

PO Box 50 310 SE-202 13 Malmö SwedenBioglan offers development and manufacturing of semi-solid and liquid products for pharmaceutical, healthcare and life science companies.

Sölvegatan 41 223 62 Lund, Sweden 046-286 85 50BioInvent offers antibody discovery and antibody-based drugs.

Kogle Allé 2 Hørsholm, DK-2970 DenmarkBioneer is a trusted strategic R&D partner to biotech and pharmaceutical companies, founded in 1982. As a R&D-driven CRO and CDMO, Bioneer specializes in delivering customized, high-quality research and manufacturing services that meet your needs. We help companies: - Discover, develop, and manufacture promising early drug candidates and recombinant proteins - Gain critical preclinical insights into the mechanisms, efficacy, safety, and formulation of their drug candidates Bioneer is specialized in Human Disease Models, Stem Cell Technology (iPSC) & Gene Editing, Human Cancer and Immune Models, CNS-focused Models, Organ models, Process Development and Manufacturing of recombinant proteins including GMP process proteins, Biomarkers incl. Histology and Drug Candidate Characterization and Formulation.

University of Copenhagen Universitetsparken 2 Copenhagen, Provision of a Service, 2100 DenmarkBioneer is a trusted strategic R&D partner to biotech and pharmaceutical companies, founded in 1982. As a R&D-driven CRO and CDMO, Bioneer specializes in delivering customized, high-quality research and manufacturing services that meet your needs. We help companies: - Discover, develop, and manufacture promising early drug candidates and recombinant proteins - Gain critical preclinical insights into the mechanisms, efficacy, safety, and formulation of their drug candidates Bioneer is specialized in Human Disease Models, Stem Cell Technology (iPSC) & Gene Editing, Human Cancer and Immune Models, CNS-focused Models, Organ models, Process Development and Manufacturing of recombinant proteins including GMP process proteins, Biomarkers incl. Histology and Drug Candidate Characterization and Formulation.

2 Kogle Alle Hørsholm, 2970 DenmarkBioneer is a trusted strategic R&D partner to biotech and pharmaceutical companies, founded in 1982. As a R&D-driven CRO and CDMO, Bioneer specializes in delivering customized, high-quality research and manufacturing services that meet your needs. We help companies: - Discover, develop, and manufacture promising early drug candidates and recombinant proteins - Gain critical preclinical insights into the mechanisms, efficacy, safety, and formulation of their drug candidates Bioneer is specialized in Human Disease Models, Stem Cell Technology (iPSC) & Gene Editing, Human Cancer and Immune Models, CNS-focused Models, Organ models, Process Development and Manufacturing of recombinant proteins including GMP process proteins, Biomarkers incl. Histology and Drug Candidate Characterization and Formulation.

Ole Maaløes Vej 3 Copenhagen N, Capital Region, 2200 DenmarkYour Truth Detector in Drug Development and Use, Improving Success-Rates from Targets to Patients. BioPhenyx helps our customers determine drug targets and drug responses in a multitude of settings from the earliest target discovery to patient response to therapeutics. Our proprietary CRISPR-Select technology add an extra level of insight to your targets and drug candidates: Exceptional data on the role of molecular targets in disease etiology and their responsiveness to drug candidates are critical for better development of therapeutics. This will reduce attrition rates in development programs and clinical trials. The BioPhenyx team has invented and developed the CRISPR-Select technology to generate unmatched data quality. We perform precise, fast (weeks), and quantitative analysis of a candidate drug target or a drug response in cells, where we introduce mutation(s) needed to address the question. This is done with no need for cell line generation and clonal selection. BioPhenyx helps our customers determine drug targets and drug responses in a multitude of settings from the earliest target discovery to patient response to therapeutics. Exceptional data on the role of molecular targets in disease etiology and their responsiveness to drug candidates are critical for better development of therapeutics. This will reduce attrition rates in development programs and clinical trials. The BioPhenyx team has invented and developed the CRISPR-Select technology to generate unmatched data quality. CRISPR-Select in Nature Genetics: https://www.nature.com/articles/s41588-022-01224-7. CRISPR-Select as Resarch Highlight in Nature Biotechnology: https://www.nature.com/articles/s41587-022-01647-x. We perform precise, fast (weeks), and quantitative analysis of a candidate drug target or a drug response in cells, where we introduce mutation(s) needed to address the question. This is done with no need for cell line generation and clonal selection. We may help to answer the following questions, and more: Is my mutation / variation benign or pathogenic? Is my protein or gene a good drug target? How should my drug best block / inhibit my target: - Catalytic inhibition? - Protein-protein interaction inhibition? - Elimination of protein expression? Is my drug candidate working? Does my drug act on-target?

Grusbakken 8 Gentofte, DK-2820 DenmarkBioPorto Diagnostics develops and markets antibodies and antibody-based products, including tests to diagnose human disease.

Sophienherg Vainge 30 DK-2960 Rungsted Kyst DenmarkBioProcess Technology Consultants supports process/analytical development, quality and regulatory affairs, manufacturing strategy, and supply chain management.

29 Rosenhälls vägen Härslöv, Skåne län, 261 92 SwedenALS in Europe provides analytical testing, method development and microbiology services to pharmaceutical and biotechnology clients. With strategically located GMP-compliant laboratories, ALS in Europe supports drug development, manufacturing and quality release across the product lifecycle, from raw material testing and stability studies to sterility testing and container-closure integrity.

Finsensvej 15 Room 320 Frederiksberg, 2000 DenmarkWe are data scientists with extensive project experiences in biomedical research and drug development. As a very start-up, we are eager to impress our clients with exceptionally excellent work in the sense of creativeness, quality, speed, and price. Our work includes, but not limited to: * NGS data preprocessing and analysis. (Single or bulk cell WGS, WES, RNA, epigenetic sequence data.) * Identification of biomarkers, drug target, and signaling pathways. * Prediction model for early diagnosis, prognosis, and drug responses. * Screening for pharmacological agent candidates to get a short list that can be verified in lab for new drug discovery. * For immuno-oncology, identification of neoantigens, prediction of T cell epitope, etc. * Vaccine design with machine learning. * For gene therapy, machine learning aids for novel discoveries and innovations. * Protein design and engineering. * Microbiome data analysis. * Biological and medical image analysis with artificial intelligence. * Statistical analysis and visualization.

Østerbrogade 95 Copenhagen, DK-2100 DenmarkBiotech-IgG supplies chromatography resins and columns, cell culture media, and immunodiagnostic assay kits and reagents.

Copenhagen DenmarkBiotech-IgG supplies chromatography resins and columns, cell culture media, and immunodiagnostic assay kits and reagents.

Smedevangen 5 3540 Lynge, DenmarkBrogaarden provides specialty products for companion animals, exotic animals and laboratory animal science, such as horses, dog,s and rodents. We are specialized in nutrition

Marielundvej 39 DK-2730 HerlevBuch & Holm provides lab consumables, safety equipment, and other laboratory equipment.

Herlev, 2730 DenmarkBuch & Holm provides lab consumables, safety equipment, and other laboratory equipment.

Box 7065 307 Halmstad SwedenCanilab-Equilab is a veterinary consultant laboratory, with a specialization in clinical chemistry.

Bergman Hessle AB Ingelstorpsv. 229 S-262 92 Ängelholm SwedenCapra Science provides antibody production and purification services.

c/o Scion Technical University of Denmark Diplomvej 381 2800 Kongens Lyngby DenmarkPEPTIDE SYNTHESIS CASLO ApS offers custom peptide synthesis, peptide modifications and polyclonal anti-peptide antibody production services.

CASLO ApS c/o Scion Denmark Technical University Diplomvej , Lyngby , 381 DK-2800 DenmarkPEPTIDE SYNTHESIS CASLO ApS offers custom peptide synthesis, peptide modifications and polyclonal anti-peptide antibody production services.

Lund, SwedenCellaVision offers analyzers, review software, competency software, and blood smearing devices.

Lund, Skåne County SwedenCellaVision offers analyzers, review software, competency software, and blood smearing devices.

1 Scheeletorget Skåne län, 223 63 SwedenCellevat3dTM NanoMatriceTM is a nanofiber-based platform designed for in vitro testing that can be used as a powerful tool for studying cells in 3D applications due to its high resemblance to the extracellular matrix. Since Cellevate was founded in 2014 in Lund, Sweden, we have worked with our collaborators in most fields of life science research, primarily focusing on the areas of neurology, oncology, immunology, and many others. Cellevat3dTM NanoMatriceTM based products for Neuro applications have already been successfully used and generated results in cell culture applications. Cellevat3dTM NanoMatriceTM is specifically useful when working with iPSCs.

Technical University of Denmark, Kemitorvet, Building 208, DK-2800 Lyngby, DenmarkCenter for Biological Sequence Analysis provides bioinformatic tools for genomic and proteomic services.

BMC C13, Klinikgatan 28, Lund Lund, 221 00 SwedenLund University was founded in 1666 and is ranked among the world’s top 100 universities. The University has 40 000 students and 8 160 staff based in Lund, Helsingborg and Malmö. We are united in our efforts to understand, explain and improve our world and the human condition. Education and research Lund is the most popular study location in Sweden. The University offers one of the broadest ranges of programmes and courses in Scandinavia, based on cross-disciplinary and cutting-edge research. The University has a distinct international profile, with partner universities in 70 countries. Lund University has an annual turnover of SEK 8.8 billion, of which close to 60% goes to research. Our research is characterised by both breadth and strength. We provide education and research within the following areas: Economics and management Engineering and technology Humanities Theology Law Fine arts, music and theatre Medicine Science Social sciences World-leading research facilities Two of the world’s foremost research facilities for materials research and life science are established in Lund. MAX IV, which was inaugurated in June 2016, is the leading synchrotron radiation facility in the world. The European research facility ESS will be the world’s most powerful neutron source when it opens for research in 2023. MAX IV and ESS will have a major impact on future scientific and industrial development in both materials science and life science. Ideon Science Park, Medicon Village and Science Village Scandinavia are closely linked to Lund University, integrating research, innovation and entrepreneurship.

Box 117 SE-221 00 Lund Box 117 SE-221 00 Lund Lund, Lund, 221 00 SwedenLund University was founded in 1666 and is ranked among the world’s top 100 universities. The University has 40 000 students and 8 160 staff based in Lund, Helsingborg and Malmö. We are united in our efforts to understand, explain and improve our world and the human condition. Education and research Lund is the most popular study location in Sweden. The University offers one of the broadest ranges of programmes and courses in Scandinavia, based on cross-disciplinary and cutting-edge research. The University has a distinct international profile, with partner universities in 70 countries. Lund University has an annual turnover of SEK 8.8 billion, of which close to 60% goes to research. Our research is characterised by both breadth and strength. We provide education and research within the following areas: Economics and management Engineering and technology Humanities Theology Law Fine arts, music and theatre Medicine Science Social sciences World-leading research facilities Two of the world’s foremost research facilities for materials research and life science are established in Lund. MAX IV, which was inaugurated in June 2016, is the leading synchrotron radiation facility in the world. The European research facility ESS will be the world’s most powerful neutron source when it opens for research in 2023. MAX IV and ESS will have a major impact on future scientific and industrial development in both materials science and life science. Ideon Science Park, Medicon Village and Science Village Scandinavia are closely linked to Lund University, integrating research, innovation and entrepreneurship.

BMC C13, Klinikgatan 28, Lund Lund, Lund, 221 00 SwedenLund University was founded in 1666 and is ranked among the world’s top 100 universities. The University has 40 000 students and 8 160 staff based in Lund, Helsingborg and Malmö. We are united in our efforts to understand, explain and improve our world and the human condition. Education and research Lund is the most popular study location in Sweden. The University offers one of the broadest ranges of programmes and courses in Scandinavia, based on cross-disciplinary and cutting-edge research. The University has a distinct international profile, with partner universities in 70 countries. Lund University has an annual turnover of SEK 8.8 billion, of which close to 60% goes to research. Our research is characterised by both breadth and strength. We provide education and research within the following areas: Economics and management Engineering and technology Humanities Theology Law Fine arts, music and theatre Medicine Science Social sciences World-leading research facilities Two of the world’s foremost research facilities for materials research and life science are established in Lund. MAX IV, which was inaugurated in June 2016, is the leading synchrotron radiation facility in the world. The European research facility ESS will be the world’s most powerful neutron source when it opens for research in 2023. MAX IV and ESS will have a major impact on future scientific and industrial development in both materials science and life science. Ideon Science Park, Medicon Village and Science Village Scandinavia are closely linked to Lund University, integrating research, innovation and entrepreneurship.

Hestehavevej 36 A Lille Skensved, 4623 DenmarkFor over 75 years, Charles River has provided essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe, helping to accelerate their research and drug development efforts. With over 90 sites globally, we’re ready to tackle your product’s most unique challenges. Our focus on timeliness and accuracy in every stage of drug development means you can count on us to deliver reliable results – every step of the way. Visit our website to learn more about our portfolio and how we can support your research. www.criver.com

Gydevang 43, DK-3450 Allerod, DenmarkChemoMetec A/S provides solutions for cell sample analysis in a very wide range of applications within medicine and the life sciences. The NucleoCounter® product range consists of fluorescent-based cell counters and advanced flexible cell analyzers. The technology is based on state-of-the-art image cytometry combined with an innovative and user-friendly interface. Built-in assays covering cell count and viability determination, cell cycle analysis, GFP transfection efficiency and every stage of apoptosis ensure fast and robust cell analysis results. A wide range of user-definable protocols offer a platform for studying the distribution of fluorescent biomarkers. The NucleoCounters® range can be implemented at every stage, from R&D to production, to ensure high levels of stability and reproducibility.

43 Gydevang Lillerød, 3450 DenmarkChemoMetec A/S provides solutions for cell sample analysis in a very wide range of applications within medicine and the life sciences. The NucleoCounter® product range consists of fluorescent-based cell counters and advanced flexible cell analyzers. The technology is based on state-of-the-art image cytometry combined with an innovative and user-friendly interface. Built-in assays covering cell count and viability determination, cell cycle analysis, GFP transfection efficiency and every stage of apoptosis ensure fast and robust cell analysis results. A wide range of user-definable protocols offer a platform for studying the distribution of fluorescent biomarkers. The NucleoCounters® range can be implemented at every stage, from R&D to production, to ensure high levels of stability and reproducibility.

Boege Alle 10-12 Hoersholm , 2970 DenmarkChr. Hansen is a global bioscience company that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. We have been around since 1874 and have more than 2,700 dedicated employees in more than 30 countries. As a company we aim to deliver innovative natural solutions that advance food, health and productivity for the benefit of us all. We develop and produce cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed and plant protection. +Food Cultures & enzymes+ We assist you in optimizing production processes, increasing yields and improving quality. Our microbial and enzymatic solutions are cutting-edge functional tools let you produce great-tasting, consistent products; be they dairy products, meats or wine. +Natural Colors+ Today, Chr. Hansen is the only provider of natural colors that combines 140 years of unique application and regulatory expertise with a strong, extensive global presence and the widest natural color portfolio in the industry. Whether you are changing from artificial to natural colors or to food and vegetable concentrates and juices, we understand your challenges. We work collaboratively with you, bringing ideas, expertise and solutions to every stage of the process – from the first product brief to the supermarket shelves.

Hellerupvej 17 A Hellerup, 2900 Denmark

Fruebjergvej 3 Copenhagen, DK-2100 DenmarkAt Cmbio, we are innovators at the forefront of microbiome science and multi-omics research. Our team of over 100 experts spans microbiology, bioinformatics, metabolomics, molecular biology, and data science, bringing unparalleled expertise to advance the understanding and impact of the microbiome in global health. With labs in both the US and EU and a presence across the US, EU, and APAC regions, we are dedicated to creating breakthrough tools and analytical techniques that set new standards for the field. Together, we drive innovation to transform health and sustainability worldwide. The company comprises four integrated entities: Clinical Microbiomics, DNASense, MS-Omics, and CosmosID. Together, bringing multiomics expertise in metagenomics, genomics, transcriptomics, proteomics, metabolomics, bioinformatics, and global multi-omics studies including kitting services, positioning Cmbio as a leader in the microbiome field. We serve a diverse range of applications across human, animal, industrial, and environmental sectors, emphasizing innovation, quality, and client collaboration.

3 Ole Maaløes Vej København, 2200 DenmarkAt Cmbio, we are innovators at the forefront of microbiome science and multi-omics research. Our team of over 100 experts spans microbiology, bioinformatics, metabolomics, molecular biology, and data science, bringing unparalleled expertise to advance the understanding and impact of the microbiome in global health. With labs in both the US and EU and a presence across the US, EU, and APAC regions, we are dedicated to creating breakthrough tools and analytical techniques that set new standards for the field. Together, we drive innovation to transform health and sustainability worldwide. The company comprises four integrated entities: Clinical Microbiomics, DNASense, MS-Omics, and CosmosID. Together, bringing multiomics expertise in metagenomics, genomics, transcriptomics, proteomics, metabolomics, bioinformatics, and global multi-omics studies including kitting services, positioning Cmbio as a leader in the microbiome field. We serve a diverse range of applications across human, animal, industrial, and environmental sectors, emphasizing innovation, quality, and client collaboration.

Bygstubben 9 Vedbæk, 2950 DenmarkAt Cmbio, we are innovators at the forefront of microbiome science and multi-omics research. Our team of over 100 experts spans microbiology, bioinformatics, metabolomics, molecular biology, and data science, bringing unparalleled expertise to advance the understanding and impact of the microbiome in global health. With labs in both the US and EU and a presence across the US, EU, and APAC regions, we are dedicated to creating breakthrough tools and analytical techniques that set new standards for the field. Together, we drive innovation to transform health and sustainability worldwide. The company comprises four integrated entities: Clinical Microbiomics, DNASense, MS-Omics, and CosmosID. Together, bringing multiomics expertise in metagenomics, genomics, transcriptomics, proteomics, metabolomics, bioinformatics, and global multi-omics studies including kitting services, positioning Cmbio as a leader in the microbiome field. We serve a diverse range of applications across human, animal, industrial, and environmental sectors, emphasizing innovation, quality, and client collaboration.

8 Bygstubben Vedbæk, Hovedstaden, 2950 DenmarkAt Cmbio, we are innovators at the forefront of microbiome science and multi-omics research. Our team of over 100 experts spans microbiology, bioinformatics, metabolomics, molecular biology, and data science, bringing unparalleled expertise to advance the understanding and impact of the microbiome in global health. With labs in both the US and EU and a presence across the US, EU, and APAC regions, we are dedicated to creating breakthrough tools and analytical techniques that set new standards for the field. Together, we drive innovation to transform health and sustainability worldwide. The company comprises four integrated entities: Clinical Microbiomics, DNASense, MS-Omics, and CosmosID. Together, bringing multiomics expertise in metagenomics, genomics, transcriptomics, proteomics, metabolomics, bioinformatics, and global multi-omics studies including kitting services, positioning Cmbio as a leader in the microbiome field. We serve a diverse range of applications across human, animal, industrial, and environmental sectors, emphasizing innovation, quality, and client collaboration.

Copenhagen DenmarkCMC Biologics offers cell line development, purification, and characterization services.

Vandtaarnsvej 83B DK-2860 Soeborg, Copenhagen DenmarCMC Biologics offers cell line development, purification, and characterization services.

Bækholmen 25 Danmark Måløv, 2760 DenmarkCOBO Technologies is a fast-growing company located in Copenhagen, Denmark, that develop tools and services based around the CRISPR/Cas9 technology. The powerful INDEL Profiling Platform, CIPP™, was launched in December 2017 and in January 2019 they launched the Protein Expression analysis Platform, PIPPR™. Both platforms are today used to do Quality Control of cells modified with CRISPR, ZFNs or TALENs.

KONG GEORGS VEJ 12 Frederiksberg, 2000 DenmarkCOBO Technologies is a fast-growing company located in Copenhagen, Denmark, that develop tools and services based around the CRISPR/Cas9 technology. The powerful INDEL Profiling Platform, CIPP™, was launched in December 2017 and in January 2019 they launched the Protein Expression analysis Platform, PIPPR™. Both platforms are today used to do Quality Control of cells modified with CRISPR, ZFNs or TALENs.

Ved Klaedebo 14 DK-2970 HORSHOLM Region Hovedstaden DenmarkCODAN provides disposable medical transfer systems, such as IV delivery.

Hørsholm, 2970 DenmarkCODAN provides disposable medical transfer systems, such as IV delivery.

Sandet 6 Bjaeverskov, 4632 DenmarkCook MyoSite offers single-donor primary human skeletal muscle cells (skMDC) characterized by age, gender, race, and BMI with optimized media (MyoTonic, CryoTonic) to make cell culture growth, differentiation, and cryopreservation as reliable as possible in your lab. We offer healthy and diseased cells from a range of donors, and we can generate gene expression profiles for each lot of cells to further characterize expression levels of myogenic gene targets. At Cook MyoSite, our services are backed by nearly two decades of clinical experience in muscle-related research. skMDC are isolated and processed using only the highest quality materials, and our highly experienced Laboratory Research Services team provides expert customer service and technical support to ensure that the cells perform as expected. • Skeletal Muscle Cells Use the highest quality, most characterized primary human skeletal muscle cells (skMDC) on the market. Healthy and neuromuscular diseased cells are available. • MyoTonic™ Family of Culture Media Specifically formulated basal medium, growth supplements, and differentiation media for human skeletal muscle cells. Some offerings are available in serum-free or insulin-free configurations. • CryoTonic™ Cryostorage Medium Preserve your valuable cell stocks and maintain high viability post-thaw with a high-quality cryopreservation medium. All Cook MyoSite offerings are for research use only (RUO). Please review our Product Use Guidelines at https://www.cookmyosite.com/skmdc In addition to our standard cell and media offerings, Cook MyoSite provides a range of custom services from modified cell samples to contract manufacturing arrangements. If your organization is interested in our custom services, fill out the form in the "Inquire" tab and a representative will be in touch shortly to discuss your specific needs. Potential services include: • Cells cryopreserved at a specific passage • Procurement and processing of muscle cells from a specific donor population • Custom media formulations • CMO/CDMO arrangements • QC analytical testing and assay development Company History In 2002, Cook MyoSite, Incorporated was formed to guide the Cook Group organization into the expanding world of cellular technologies. In 2008, Cook MyoSite began developing and commercializing high-quality primary muscle cells and associated reagents. Cook MyoSite is committed to providing the research community with products to research and develop cellular treatments for a variety of disorders. Today, Cook MyoSite is dedicated to the development and subsequent commercialization of technology related to the collection, selection, and expansion of human skeletal muscle cells for the treatment of various disorders.

2 Scheelevägen Scheelevägen 2 Skåne län, 223 63 Sweden

Teglgården 60 PO Box 130 Birkerød, 3460 DenmarkCyncron is a full service phase I-IV drug development company offering in-house expertise in clinical operations, clinical pharmacology, biometrics, medical affairs, pharmacovigilance, quality management and consultancy services.

Birkerød, Capital Region of Denmark, 3460 DenmarkCyncron is a full service phase I-IV drug development company offering in-house expertise in clinical operations, clinical pharmacology, biometrics, medical affairs, pharmacovigilance, quality management and consultancy services.

Medicon Village Lund, 223 81 SwedenCytely is a cloud-based platform for standardized biological measurement. We help pharma and biotech teams make cell-based assays reproducible, auditable, and analyst-independent. Teams upload data from any microscope and get automated quantification with full data provenance from raw image to final result. No code, no specialist analysts, no local infrastructure required. Built on Data-Driven Microscopy, a peer-reviewed framework published in Cell Reports Methods, and founded in Lund, Sweden.

Nordre Strandvej 119F Hellebaek, DK-3150 DenmarkCytotech has specialised in the production and marketing of animal and normal human cell systems and related media for in vitro research, serum-free and customized media, sera, growth factors and supplements. The company has an impressive range of immunology reagents, mono- and polyclonal antibodies available for research.

1D Gammel Lundtoftevej Kongens Lyngby, 2800 DenmarkCytoTrack ApS was established in 2004, and the first product was released on the market in 2011. CytoTrack is an affiliate of the engineering consultancy 2C A/S. he technology was invented as a part of a research development project at The National Hospital of Denmark. The project was headed by Professor John Philip.The application was to identify FCMB (Foetal Cells in Maternal Blood). The project discovered that conventional instruments such as flowcytometry and common fluorescent scanners were not good enough for this type of application and could not detect the extremely rare foetal cells and could not offer features for molecular characterization. The CytoTrack technology was invented and developed specifically for the challenges of rare cell detection by Christian Caspersen. Other applications such as detection of CTCs were soon adopted. In 2004, the first recognized paper about CTCs were published in The New England Journal of Medicine. This paper was the first to demonstrate the clinical value of enumeration of CTCs. Since then, CytoTrack has developed and optimized CytoTrack technology to show breakthrough performance within the CTC application. In 2011, CytoTrack commercially released the CytoTrack technology.

Gl. Lundtoftevej 1D DK-2800 LyngbyCytoTrack ApS was established in 2004, and the first product was released on the market in 2011. CytoTrack is an affiliate of the engineering consultancy 2C A/S. he technology was invented as a part of a research development project at The National Hospital of Denmark. The project was headed by Professor John Philip.The application was to identify FCMB (Foetal Cells in Maternal Blood). The project discovered that conventional instruments such as flowcytometry and common fluorescent scanners were not good enough for this type of application and could not detect the extremely rare foetal cells and could not offer features for molecular characterization. The CytoTrack technology was invented and developed specifically for the challenges of rare cell detection by Christian Caspersen. Other applications such as detection of CTCs were soon adopted. In 2004, the first recognized paper about CTCs were published in The New England Journal of Medicine. This paper was the first to demonstrate the clinical value of enumeration of CTCs. Since then, CytoTrack has developed and optimized CytoTrack technology to show breakthrough performance within the CTC application. In 2011, CytoTrack commercially released the CytoTrack technology.

Produktionsvej 42 Glostrup, DK-2600 DenmarkDako delivers world class diagnostic reagents, kits and instruments for fast and accurate answers for cancer patients and doctors making vital decisions for treatment.

Ole Maaløes Vej 3 Copenhagen, 2200 DenmarkDeepCyte is a biotech startup pioneering single-cell metabolomics using high-throughput MALDI mass spectrometry. We help pharma partners map cellular metabolism at scale to accelerate drug discovery and precision medicine.

Ringsted, 4100 DenmarkDerma Veris offers consulting and formulation development services for dermatological products.

Western Hedevej 15, 4000 Roskilde DenmarkDorte Egelund provides microbiology services.

Winstrupsgatan 1 Lund, 22222 SwedenEDC Scandinavia collects data for clients in life science Our mission is to plan, collect, and support electronic data capture using an effective combination of experience and knowledge, together with relevant services and support, to select and set up the technology. Independent selection of the technology platform ensures the right solution for your company. This not only lowers costs, but the Knowledge-Based Planning & set-up offered by EDC Scandinavia prevents unnecessary changes, delays and other issues. The personnel at EDC Scandinavia have in-depth experience in technology and drug development, so you can be very confident in the services we offer.

381 Kongevejen Holte, Hovedstaden, 2840 DenmarkEIR Sciences is a contract research company providing services related to immunogenicity assessment and optimization of protein based medicines and biopharmaceuticals in order to save resources by reducing drug failure risk and speed up the process towards late stage pipeline products. Our vision & mission: EIR Sciences aspire to be the preferred partner within immunogenicity assessment. EIR Sciences is dedicated to reduce risk of failure and aid faster decision making in biopharmaceutical drug development. Our promise: Transparency - we are committed to provide our clients with transparency of the methods and technology we use and the services we provide. Cooperation - we go the extra mile to fulfill the specific needs of our clients. World-class technologies - our technologies are based on award-winning and state-of-the-art methods, which are constantly improved and assessed by the global scientific community. Strong scientific foundation – the EIR sciences team comprise some of the worlds leading experts in immunologic bioinformatics and immune assays

Vadgårdsvej 22B Søborg, 2860 DenmarkEIR Sciences is a contract research company providing services related to immunogenicity assessment and optimization of protein based medicines and biopharmaceuticals in order to save resources by reducing drug failure risk and speed up the process towards late stage pipeline products. Our vision & mission: EIR Sciences aspire to be the preferred partner within immunogenicity assessment. EIR Sciences is dedicated to reduce risk of failure and aid faster decision making in biopharmaceutical drug development. Our promise: Transparency - we are committed to provide our clients with transparency of the methods and technology we use and the services we provide. Cooperation - we go the extra mile to fulfill the specific needs of our clients. World-class technologies - our technologies are based on award-winning and state-of-the-art methods, which are constantly improved and assessed by the global scientific community. Strong scientific foundation – the EIR sciences team comprise some of the worlds leading experts in immunologic bioinformatics and immune assays

Diplomvej 381 2800 Kgs.Lyngby DenmarkEIR Sciences is a contract research company providing services related to immunogenicity assessment and optimization of protein based medicines and biopharmaceuticals in order to save resources by reducing drug failure risk and speed up the process towards late stage pipeline products. Our vision & mission: EIR Sciences aspire to be the preferred partner within immunogenicity assessment. EIR Sciences is dedicated to reduce risk of failure and aid faster decision making in biopharmaceutical drug development. Our promise: Transparency - we are committed to provide our clients with transparency of the methods and technology we use and the services we provide. Cooperation - we go the extra mile to fulfill the specific needs of our clients. World-class technologies - our technologies are based on award-winning and state-of-the-art methods, which are constantly improved and assessed by the global scientific community. Strong scientific foundation – the EIR sciences team comprise some of the worlds leading experts in immunologic bioinformatics and immune assays

25 Trollesmindealle Hillerød, 3400 Denmark

Building 401 Medicon Village Scheelevägen 2 SE-223 63 Lund, SwedenEmmace Consulting offers excellence in performance testing of pharmaceutical inhalation products on a CRO-basis and base the service on:

medicon village 223 81 Lund SwedenEmmace Consulting offers excellence in performance testing of pharmaceutical inhalation products on a CRO-basis and base the service on:

Copenhagen, Capital Region of Denmark DenmarkEntomoPharm offers in vivo and ex vivo blood brain barrier insect models to support pre-clinical ADMET testing.

Fruebjergvej 3 Copenhagen, DK-2100 DenmarkEntomoPharm offers in vivo and ex vivo blood brain barrier insect models to support pre-clinical ADMET testing.

Danneskiold-Samsoees Allé 41 Copenhagen, 1434 DenmarkLiver fibrosis biomarker for correct classification of fibrosis stages

Lersoe Parkallé 42-44 DK-2100 Copenhagen OE DenmarkEvolva provides products and processes to companies in the food and beverage, consumer health and pharmaceutical sectors.

Exiqon A/S, Skelstedet 16 , 2950 Vedbaek, Denmark.Exiqon operates in two business areas: Life Sciences and Diagnostics. Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and the development of cancer and other diseases. Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences. Exiqon is listed on the NASDAQ Copenhagen.

Agern Alle 1 Danmark Horsholm, Denmark, 2970 DenmarkExpreS2ion Biotechnologies offers protein expression and purification services in Drosophila Schneider-2 (S2) cells, the proprietary ExpreS2 system. We also establish cell lines for R&D as well as for manufacturing of GMP master cell banks (MCBs), and provide process development support. We are currently running clinical phase 1 and 2 trials with proteins produced in ExpreS2

SCION-DTU Science Park Agern Allé 1 Horsholm, DK-2970 DenmarkExpreS2ion Biotechnologies offers protein expression and purification services in Drosophila Schneider-2 (S2) cells, the proprietary ExpreS2 system. We also establish cell lines for R&D as well as for manufacturing of GMP master cell banks (MCBs), and provide process development support. We are currently running clinical phase 1 and 2 trials with proteins produced in ExpreS2

Universitetsparken 2 Copenhagen, 2100 DenmarkFidabio Aps has developed a new patented solution for rapid assessment of protein-protein interactions and protein concentration under native conditions (e.g. plasma, serum, lysate or csf). Our core product is a fully automated state-of-the-art platform. Fidabio Aps also provides consumables and software solutions for custom assay development. Since its incorporation the focus has been on securing IP, developing dedicated instrumentation, software and consumables.

Fruebjergvej 3 Copenhagen, 2100 DenmarkFidabio Aps has developed a new patented solution for rapid assessment of protein-protein interactions and protein concentration under native conditions (e.g. plasma, serum, lysate or csf). Our core product is a fully automated state-of-the-art platform. Fidabio Aps also provides consumables and software solutions for custom assay development. Since its incorporation the focus has been on securing IP, developing dedicated instrumentation, software and consumables.

Generatorvej 6, 1. sal Soeborg Copenhagen, 2860 DenmarkFidabio Aps has developed a new patented solution for rapid assessment of protein-protein interactions and protein concentration under native conditions (e.g. plasma, serum, lysate or csf). Our core product is a fully automated state-of-the-art platform. Fidabio Aps also provides consumables and software solutions for custom assay development. Since its incorporation the focus has been on securing IP, developing dedicated instrumentation, software and consumables.

2 Universitetsparken København, 2100 DenmarkFidabio Aps has developed a new patented solution for rapid assessment of protein-protein interactions and protein concentration under native conditions (e.g. plasma, serum, lysate or csf). Our core product is a fully automated state-of-the-art platform. Fidabio Aps also provides consumables and software solutions for custom assay development. Since its incorporation the focus has been on securing IP, developing dedicated instrumentation, software and consumables.

Per Albin Hansson väg 41 Malmo, SwedenGalenica specializes in preformulation/formulation, and provides analytical support for QC testing, stability, and regulatory services.

3 Ole Maaløes Vej København N, Hovedstaden, 2200 DenmarkAt GCATbio, we are revolutionizing DNA synthesis through our innovative high-throughput DNA synthesizer, mMPS (microchip-based Massive Parallel Synthesis) and the Gene Synthesis Auto Workstation, delivering high-quality, low-cost genes for a broad range of applications in life science and biotechnology. > Revolutionary mMPS Technology: Our mMPS platform harnesses thousands to millions of individually barcoded microchips, each dedicated to synthesizing a single oligonucleotide at the pmol–nmol scale. This enables: - Unmatched quality and consistency in DNA synthesis, - Scalable and flexible production for diverse research needs, and - Significant cost and time efficiencies across workflows. > The mMPS system is optimized for applications including: - Variant library construction - Custom DNA/RNA synthesis - NGS panel generation - DNA data storage Whether your research focuses on gene or genome synthesis, gene editing, antibody discovery, protein or pathway engineering, or molecular diagnostics, GCATbio’s mMPS platform empowers your innovation with speed, precision, and scalability. > Integrated Solutions for Life Science Research: Beyond synthesis, GCATbio is committed to advancing the entire research ecosystem by developing complete solutions for essential raw materials. Our portfolio includes: - Reagents, kits, and consumables (e.g., peptides, functional proteins, molecular biology reagents, and biochemicals) - Custom R&D and synthesis services - Comprehensive support for synthetic biology, protein engineering, and biochemistry research

Lund, Skåne County SwedenGenovis offers SmartEnzyme products and lab services to support antibody engineering, antibody conjugation and protein characterization.

Scheelevagen 2 Lund, SE-220 07 SwedenGenovis offers SmartEnzyme products and lab services to support antibody engineering, antibody conjugation and protein characterization.

104 Karl Johans väg Kävlinge, Skåne Län, 244 46 SwedenGenovis offers SmartEnzyme products and lab services to support antibody engineering, antibody conjugation and protein characterization.

Box 4 Kavlinge, 244 21 SwedenGenovis offers SmartEnzyme products and lab services to support antibody engineering, antibody conjugation and protein characterization.

Nielsine Nielsens Vej 4B Bispebjerg Hospital Building 80A, CTF, 2 sal Copenhagen, 2400 DenmarkGLX Analytix is an award-winning, clinical-stage, Silicon Valley-venture- and strategic-backed personalized medicine company, pioneering a groundbreaking diagnostics and monitoring platform. Its proprietary GLX Signature Platform is powered by novel vascular biology and AI technology, designed to transform the care of patients with CNS and autoimmune diseases. Leveraging advanced glycobiology research and a new class of blood biomarkers based on the glycocalyx (GLX), GLX Analytix delivers innovative solutions for therapeutic strategies. With partnerships at leading medical institutions in the United States and Europe, GLX aims to accelerate noninvasive, cost-effective, and highly accessible personalized care for patients worldwide. Recognized by industry leaders, GLX Analytix is poised to revolutionize early detection and treatment monitoring in conditions such as Major Depressive Disorder, Alzheimer’s Disease, Multiple Sclerosis, and ALS.

Fruebjergvej 3 Copenhagen, 2100 DenmarkGLX Analytix is an award-winning, clinical-stage, Silicon Valley-venture- and strategic-backed personalized medicine company, pioneering a groundbreaking diagnostics and monitoring platform. Its proprietary GLX Signature Platform is powered by novel vascular biology and AI technology, designed to transform the care of patients with CNS and autoimmune diseases. Leveraging advanced glycobiology research and a new class of blood biomarkers based on the glycocalyx (GLX), GLX Analytix delivers innovative solutions for therapeutic strategies. With partnerships at leading medical institutions in the United States and Europe, GLX aims to accelerate noninvasive, cost-effective, and highly accessible personalized care for patients worldwide. Recognized by industry leaders, GLX Analytix is poised to revolutionize early detection and treatment monitoring in conditions such as Major Depressive Disorder, Alzheimer’s Disease, Multiple Sclerosis, and ALS.

11B Hørsholm Kongevej Hørsholm, 2970 DenmarkGubra CRO services We are specialized in preclinical contract research services enabling pharmaceutical and biotechnology companies to make fast and solid data based decisions moving projects forward. Our services include preclinical studies in a wide variety of rodent models, which can be adapted according to the specific scientific question in focus. We have a very high availability of animals, which means we can start your study with short notice. Our team of highly specialized scientists have extensive experience leading studies and solving complex scientific challenges. We handle the entire process in house from in vivo pharmacology, data processing (ex vivo assays, histology, stereology, RNA sequencing, bioinformatics etc.) to the final presentation of data. We maintain a constant focus on providing solid data as well as completing projects on time, within budget and according to the highest scientific standards. Gubra Partner Programs Having engaged in a number of large partner programs, we have profound scientific capabilities and experience leading both target and drug discovery programs within Diabetes, Obesity, NASH, CKD, CVD, IPF, IBD and 3D imaging. Besides offering all necessary disciplines in-house (from molecular and in vivo pharmacology to peptide chemistry), we have professional project managers leading our partner programs. Projects are managed to meet deadlines and stay within budget while never compromising our high-quality outputs.

11B, Horsholm Kongevej Horsholm, DK-2970 DenmarkGubra CRO services We are specialized in preclinical contract research services enabling pharmaceutical and biotechnology companies to make fast and solid data based decisions moving projects forward. Our services include preclinical studies in a wide variety of rodent models, which can be adapted according to the specific scientific question in focus. We have a very high availability of animals, which means we can start your study with short notice. Our team of highly specialized scientists have extensive experience leading studies and solving complex scientific challenges. We handle the entire process in house from in vivo pharmacology, data processing (ex vivo assays, histology, stereology, RNA sequencing, bioinformatics etc.) to the final presentation of data. We maintain a constant focus on providing solid data as well as completing projects on time, within budget and according to the highest scientific standards. Gubra Partner Programs Having engaged in a number of large partner programs, we have profound scientific capabilities and experience leading both target and drug discovery programs within Diabetes, Obesity, NASH, CKD, CVD, IPF, IBD and 3D imaging. Besides offering all necessary disciplines in-house (from molecular and in vivo pharmacology to peptide chemistry), we have professional project managers leading our partner programs. Projects are managed to meet deadlines and stay within budget while never compromising our high-quality outputs.

Symbion Science Park Fruebjergvej 3 Copenhagen, DK-2100 DenmarkhBar Solutions offers computational chemistry consulting services.

4 Humlegatan Skåne län, 211 27 SwedenHoodin is a SaaS platform for automated monitoring of digital content. Make your ongoing research and insight job time and cost efficient by use of Hoodin and AI monitoring of content that range from scientific journals to social media and forums. Adapt business intelligence with Omni Observer by automizing the content monitoring process and allocate time and resources to remaining taks towards post market surveillance and pharmacovigilance. Build your automized monitoring and market research trough different objectives regarding your post marketing e.g; Product: - Own Product in industry media, news media, social media - Competition; Monitor competitive products in industry media, news media and social media. - Market; Monitor key-words and sources that 
provide valuable information about specific trends. - Science & Patents; The product/service(s) area of use. Monitor by use of key words that related to area of use, vital technology, patent databases etc. - Pharmacovigilance

Råbygatan 2 Lund, SE-223 61 SwedenIHE is a pioneer health economic research centre in Sweden with over 40 years experience. IHE has a strong academic profile with ties to Lund University and Karolinska Institutet (KI) in Stockholm. IHE is located in Lund Sweden since 1979, with an office in Stockholm. In addition to Swedish, IHE staff is fluent in several languages including English, French, German, Danish and Spanish. IHE has ongoing projects with over 50 clients around the globe, representing national authorities, pharmaceutical companies, healthcare providers, branch organisations, and patient interest Groups. As an independent research institute, working multi-disciplinary with a broad array of public and private clients, IHE aims to contribute to sound decision-making in the health care setting by bridging the gap between the academic, commercial, and health care providers. IHE specializes in applied policy analysis and health economic evaluation, using knowledge drawn from the cutting edge of international developments as well as independent in-house methods development. In addition to research, IHE also organises and teaches in various areas of health economic theory and practice on a commission basis. Since 2002, IHE also organizes a network of Swedish health economists with 200 members and annual meetings. IHEs strength lies within applied research but there has always been strong links between IHE and the academia as IHE staff holds positions at Lund University & Karolinska Institutet and/or are engaged in doctoral dissertations. IHE promotes academic excellence and frequently publishes work in peer reviewed journals and our own report series, IHE Report. We publish between 20 and 30 papers annually. During the last five years, IHE staff published more than 120 journal articles and IHE reports. We work within all disease areas but have special expertise in diabetes, cancer, dermatology, neurological diseases and rare diseases. We are familiar with the health economic aspects of all steps of a life science product's life cycle, we work with informing authorities decision making and have experience with productivity and optimisation issues in health care settings. IHE has around 33 highly qualified, multidisciplinary specialists in health economics, medical science, and statistics. Out of these, twelve PhD’s, and half the staff have 10 years experience or more. This makes IHE one of the largest team of health economists in Sweden. IHE participates regularly in scientific congresses and meetings. Active participation at such events keeps us in touch with the international frontline of research and helps us identify current debates and work in the area. It also enables us to continually develop our own competence.

Gydevang 22A Allerod, 3450 Denmark

Lund, Skåne County SwedenImaGene-iT is an independent professional science consultant company, with 8 experienced scientists with long personal experience in biological and medical science and subject matter expertise in microscopy, cell imaging and histology. We provide complete solutions for imaging, experimental work, microscope operation and data handling – “from molecule to microscope, and beyond”!

Medicon Village Scheeletorget 1 Lund, Skane, 22381 SwedenImaGene-iT is an independent professional science consultant company, with 8 experienced scientists with long personal experience in biological and medical science and subject matter expertise in microscopy, cell imaging and histology. We provide complete solutions for imaging, experimental work, microscope operation and data handling – “from molecule to microscope, and beyond”!

Medicon Village Scheeletorget 1 Lund, Please select, 22381 SwedenImaGene-iT is an independent professional science consultant company, with 8 experienced scientists with long personal experience in biological and medical science and subject matter expertise in microscopy, cell imaging and histology. We provide complete solutions for imaging, experimental work, microscope operation and data handling – “from molecule to microscope, and beyond”!

Bredevej 2A Virum, DK-2830 DenmarkImmudex ApS is a pioneering life science company and the trusted partner of scientists worldwide spearheading the global adoption of precision cellular immune monitoring. Immudex’s mission is to help researchers and clinicians unravel the complexity of the immune system, enabling the development of more effective immune-based therapeutics and diagnostics. Immudex operates globally, with headquarters in Copenhagen, Denmark, and North American operations based in Philadelphia. Immudex’s Dextramer® technology is superior for the detection of antigen-specific immune cells, including rare and low-affinity cells. Immudex offers a broad product portfolio that allows scientists to investigate diverse types of immune cells, including T cells, non-conventional T cells and B cells, with reagents tailored to specific applications. Immudex’s products are compatible with multiple platforms from flow cytometry to next generation sequencing and single-cell multi-omics. In addition to Dextramer® reagents for basic research, Immudex also provides Clinical-Grade Dextramer® (GMP) products and Dextramer® CMV Kits (IVD) manufactured in ISO 13485:2106-certified facilities, according to the requirements of FDA QSR 21 CFR 820. Immudex’s products enable scientists to get the full picture of the immune response, supporting ground-breaking advances within immuno-oncology, transplantation, autoimmune and infectious diseases. Find out more at www.immudex.com. Or reach out to us at customer@immudex.com.

42 Lersø Parkallé København, 2100 DenmarkImmunitrack is a world leading company within in-vitro peptide immunogenicity assessment. Our company has a platform technology Neoscreen aimed at validating truly immunogenic epitopes and studying T cell populations (CD4 and CD8) in human and mouse models. Our company builds on more than 20 years of experience in working in vitro with MHC molecules.s With the introduction of affinity assays 100 fold more sensitive and novel stability assays previously unavailable, a new level of precision has been introduced in the assignment of immunogenicity and in the identification of neo-epitopes. Immunitrack is so far the only company able to work with MHC class II peptide complexes in a robust and reliable way. Applications where this capability is key are many but for your company we can envision applications in the following areas: * Mapping T-cell epitopes in biologics at drug discovery/drug design stage. * Identify patient specific MHC-peptide complexes (neoantigens) from tumor infiltrating T-cells before and after check point inhibitor treatment * Powerful workflow from identification of cancer targets with strong therapeutical potential to generating TCR or TCR-like antinbodies and downstream characterisation (off target, cell killing). * Development of biomarkers. * Understanding of patient immune responses to immunotherapy on a molecular level. What we offer: * A set of capabilities including: peptide synthesis, MHC restriction of peptides, in vitro validation of T cell epitopes. * a workflow to support early TCR, TCR-LA development programs. Including target discovery, generation of TCR, TCR-LA and downstream characterisation. * Reliable assessment of neo-epitope binding to MHC I & MHC II, reducing inaccuracies and false positives by combining affinity and stability assessment of MHC/neo-epitope. * Large and expanding portfolio of MHC I & II alleles for mouse and human aligning customer requests. * In vitro assay capabilities on thousands of neo-epitopes. * Production capabilities of hundreds of biotinylated MHC/ neo-epitope complexes for T cell population studies. * a powerful platform for finding, validating and quantifying T cell responses towards cancer neo-epitopes and viral derived epitopes, via flow cytometry

Marielundvej 30, 2.sal 2730 HerlevImmunodiagnostic Systems (IDS) develops immunoassays and automated immunoanalyser technologies for use in clinical and research laboratories.

2 Scheelevägen Medicon Village Skåne län, 223 63 SwedenImmunovia’s innovative multiplexing technology (IMMrayTM) uses a single drop of serum to simultaneously measure 400+ biomarkers and provide condensed diagnostic-, prognostic- and predictive biomarker signatures. The company Immunovia has been a listed company since 2015, with shares (as IMMNOV), traded on Nasdaq First North in Stockholm and now heading for the Nasdaq Stockholm main-list (Q1 2018). The company has 40+ employees, is headquartered in Lund, Sweden; and is currently setting up reference labs in both Lund, Sweden, and Boston, USA. Technology IMMray™ is a versatile and robust platform technology for performing clinical serum proteomics, developed and optimized over 17 years at Lund University/Create Health. In contrast to genomics microarray technologies (e.g. NGS) that measure the potential risk of a future disease/drug (Rx) response, IMMray™ multiplexes the patient serum proteome and assesses the actual current state of the disease/treatment response. The arrays are developed from a proprietary set (currently 970) recombinant single chain fragment variant (scFV) antibodies from our own phage-display library and are able to detect changes in immuno-regulatory factors, cytokines, enzymes, complement proteins, innate factors, and cancer associated proteins. Diagnostic workflow IMMray™ is optimized for routine diagnostic lab workflows with three day’s turnaround time (TAT) from patient sample received to test report. Disease areas IMMrayTM has shown its applicability within two main disease areas – oncology (pancreatic) and autoimmune s (rheumatoid arthritis, Systemic Lupus Erythematosus, vasculitis, Sjogrens Syndrome). The key advantages, using IMMrayTM includes the ability to work with serum samples as opposed to biopsies, and, the achievement of very high clinical sensitivities and specificities to successfully differentiate between phenotypically similar indications. Our pharma offerings For our pharma partners, we design Customized Discovery Chips and IMMray™ CDx Test solutions for patient cohort dichotomization. After an initial survey of our 400+ serum biomarkers, we use our proprietary bioinformatics tools to derive a specific condensed signature/algorithm of 5-35 proteins capable of differentiating patients into sub-cohorts. This enables patient selection with sensitivities and specificities above 95%. Initially, IMMray™ product testing will be performed through our reference laboratories in Lund, Sweden and Boston, USA.

Ole Maaløes Vej 3 DK-2200 Copenhagen N Denmark Copenhagen, Copenhagen, 2200 DenmarkInnomics Inc. boasts nearly two decades of profound expertise in multi-omics (Genomics, Transcriptomics, Epigenomics, Proteomics and Metabolomics), offering end-to-end next-generation sequencing (NGS) and mass spectrometry solutions to researchers and healthcare professionals. Through the utilization of advanced technologies, a steadfast commitment to continuous innovation, spanning almost 20 years, of delivering exceptional US local lab services, Innomics ensures cost-effective, high-quality solutions. Our aim is to assist clients in swiftly and effectively achieving their research objectives.

IDEO Science Park Lund, 22370 SwedenInnovagen provides custom services such as antibody development, antibody engineering, recombinant protein expression, peptide synthesis. A range of catalog antibodies and peptides are also available.

IDEON Gamma Rec Ideongatan 1A Lund, 22362 SwedenInnovagen provides custom services such as antibody development, antibody engineering, recombinant protein expression, peptide synthesis. A range of catalog antibodies and peptides are also available.

SE-22370 LUND SWEDENInnovagen provides custom services such as antibody development, antibody engineering, recombinant protein expression, peptide synthesis. A range of catalog antibodies and peptides are also available.

c/o Christian Brueffer Kulgränden 15B LGH 1203 Lund, 22649 SwedenWe are a consulting company and contract research organization (CRO) providing hands-on bioinformatics and data science services and advice with a specialization on clinical bioinformatics, genomics and other omics modalities, oncology, precision medicine, and biomedical data science.

Diplomvej 377 Lyngby, 2800 DenmarkIntomics is specialised in deriving core biological insights from analysis and integration of biomedical big data. We increase the success rate of drug discovery and development projects for clients in the pharmaceutical industry. To each client and project we deliver scientifically solid and innovative data analysis solutions tailored by our panel of world-leading experts, executed by our experienced professionals, and based on our unique technology with value-added data sets and sophisticated systems biology platform

Medicon Village Scheeletorget 1 Lund, 223 81 SwedenIVRS is a preclinical CRO which provides innovating drug validation studies both in vitro and in vivo allowing to accelerate the drug development process for unmet needs related to severe human diseases. By using animal models we are specialized in providing 3D images to: - characterize disease progression - follow the therapeutic effect throughout the complete experimental time frame - the circulation and spreading of your candidate drug in the whole body and targeted organs - monitor pharmacokinetic/pharmacodynamic of probe distribution in vivo

10 Magnus Stenbocksgatan Skåne län, 222 24 SwedenK Bolin Healtheconomics is a consulting company with professor Kristian Bolin as the sole owner. Professor Bolin is the responsible researcher for all consulting assignments accepted by the company.

Kuldyssen 10 Taastrup, DK-2630 DenmarkKem-En-Tec Diagnostics is Europe’s leading producer of ELISA substrates and buffers for immunoassays. We deliver ELISA, immunoblotting and immunohistochemistry components to biotech, pharmaceutical and immunoassay manufacturers and research laboratories in more than 30 countries worldwide. Kem-En-Tec Diagnostics enables IVD manufacturers and research labs to create their own safe, reliable kits for fast, accurate and early diagnosis. Kem-En-Tec Diagnostics has pioneered the development of eco-sensible products (ECO-TEK). Environmentally-friendly components designed to significantly reduce facility water, waste and energy use without compromising quality, stability and accuracy. Likewise, we seek to eliminate the use of biological and chemical hazards commonly used in ELISA development and production.

Limhamnsgardens alle 9 SE 216 16 Malmo, SwedenLarodan Fine Chemicals provides lipids and research chemicals.

Strandhaven 12, Vallensbak Strand, DK-2665 DenmarkLonza is one of the world’s largest contract development and manufacturing organizations (CDMOs) dedicated to serving the healthcare industry. Working across five continents, our colleagues work alongside pharma and biotech companies to turn their breakthrough innovations into viable therapies. We support our customers in bringing life-saving and life-enhancing treatments to patients worldwide with a combination of cutting-edge science, smart technology and lean manufacturing.

Glostrup, 2600 DenmarkLundbeck Foundation Center for Neurovascular Signaling (LUCENS) focuses on research in migraine, experimental stroke, schizophrenia, and ocular diseases.

Skåne län, 223 62 Sweden

Lund, Skåne län Sweden

Agneslundsvägen 27 Malmö, 212 15 SwedenCDMO for the development of drug substance, analytical development, fill & finish and lyophilization. Separate CRO site for the solid-state characterization of pharmaceutical drug substances and drug products.

Scheelevägen 8 Lund, 223 63 SwedenCDMO for the development of drug substance, analytical development, fill & finish and lyophilization. Separate CRO site for the solid-state characterization of pharmaceutical drug substances and drug products.

Medicon Village Delivery to: Godsmottagning, Byggnad 402A Lund, Lund, SE-22381 SwedenMedetect is a CRO with specialist competence in histology and histopathology research. Medetect has since 2008 successfully contributed with new scientific knowledge within the inflammatory field in collaborations with academic and clinical researchers and in target validation projects for the pharmaceutical industry. Medetect can offer, in addition to consultancy within histological research, an unique histological technical platform including but not limited to the own developed image analysis software cell community viewer (CCV) and advanced and cutting-edge techniques for multiplex immune staining e.g. Additive Multiple Labeling Cytochemistry (AMLC), a pioneering novel technique patented and owned by Medetect AB.

Medicon Village Lund, Lund, SE-22381 SwedenMedetect is a CRO with specialist competence in histology and histopathology research. Medetect has since 2008 successfully contributed with new scientific knowledge within the inflammatory field in collaborations with academic and clinical researchers and in target validation projects for the pharmaceutical industry. Medetect can offer, in addition to consultancy within histological research, an unique histological technical platform including but not limited to the own developed image analysis software cell community viewer (CCV) and advanced and cutting-edge techniques for multiplex immune staining e.g. Additive Multiple Labeling Cytochemistry (AMLC), a pioneering novel technique patented and owned by Medetect AB.

Ole Maaløesvej 3 DK-2200 Copenhagen DenmarkMedicollect recruites volunteers for clinical trials. Faster, safer and more reliable. Medicollect's unique offering: Patients are referred to sites within 2-4 weeks, because we have a database with volunteers registred and motivated No cure no pay - Medicollect only charges per randomised patient. Low work burden for site teams - referrels are telephone pre-screened by a trained Medicollect nurse Medicollect is an international company with global ambitions. We strive to be the leading provider of patient recruitment in Europe. Medicollect is vendor qualified with some of the largest pharma companies Sanofi, Novartis, MSD as well as CRO's like Medpace.

Erikslustvägen 22 Malmö, 217 73 SwedenMedicollect recruites volunteers for clinical trials. Faster, safer and more reliable. Medicollect's unique offering: Patients are referred to sites within 2-4 weeks, because we have a database with volunteers registred and motivated No cure no pay - Medicollect only charges per randomised patient. Low work burden for site teams - referrels are telephone pre-screened by a trained Medicollect nurse Medicollect is an international company with global ambitions. We strive to be the leading provider of patient recruitment in Europe. Medicollect is vendor qualified with some of the largest pharma companies Sanofi, Novartis, MSD as well as CRO's like Medpace.

Erikslustvägen 22 217 73 Malmö SwedenMedicollect recruites volunteers for clinical trials. Faster, safer and more reliable. Medicollect's unique offering: Patients are referred to sites within 2-4 weeks, because we have a database with volunteers registred and motivated No cure no pay - Medicollect only charges per randomised patient. Low work burden for site teams - referrels are telephone pre-screened by a trained Medicollect nurse Medicollect is an international company with global ambitions. We strive to be the leading provider of patient recruitment in Europe. Medicollect is vendor qualified with some of the largest pharma companies Sanofi, Novartis, MSD as well as CRO's like Medpace.

Copenhagen, Capital Region of Denmark DenmarkMEDICON conducts clinical trials in phase II, phase III and phase IV levels.

Lund, Skåne County SwedenMetina supplies reference and fine chemicals.

Ekonomigatan 4 SE-216 13 Limhamn, Malmö SwedenMicLev AB provides diagnostic products for industrial microbiology and contamination control.

Scheelevägen 22MicroMorph offers histopathology studies, toxicology studies, histology, immunohistochemistry, special staining, in situ hybridization and microscopical analysis services.

Noerre Alle 14 Building 12.3 Copenhagen N, 2200 DenmarkMinerva Imaging is a contract research organization specializing in molecular imaging services for accelerated and efficient drug development. We help our clients to reduce the cost and risk of drug development by incorporating preclinical imaging early in the process. In collaboration with our clients we design and conduct tailored molecular imaging protocols to i.e measure drug on target effects, eliminate dead end compounds, and increase the value of lead drug candidates. We facilitate clinical testing and design of adaptive clinical trials using molecular imaging to increase the speed of clinical testing.

Ole Maaløes Vej 3 Copenhagen N, DK-2200 DenmarkMinerva Imaging is a contract research organization specializing in molecular imaging services for accelerated and efficient drug development. We help our clients to reduce the cost and risk of drug development by incorporating preclinical imaging early in the process. In collaboration with our clients we design and conduct tailored molecular imaging protocols to i.e measure drug on target effects, eliminate dead end compounds, and increase the value of lead drug candidates. We facilitate clinical testing and design of adaptive clinical trials using molecular imaging to increase the speed of clinical testing.

Lyshoejvej 21 Oelstykke, Danmark, 3650 DenmarkMinerva Imaging is a contract research organization specializing in molecular imaging services for accelerated and efficient drug development. We help our clients to reduce the cost and risk of drug development by incorporating preclinical imaging early in the process. In collaboration with our clients we design and conduct tailored molecular imaging protocols to i.e measure drug on target effects, eliminate dead end compounds, and increase the value of lead drug candidates. We facilitate clinical testing and design of adaptive clinical trials using molecular imaging to increase the speed of clinical testing.

Lyshoejvej 21 Oelstykke, 3650 DenmarkMinerva Imaging is a contract research organization specializing in molecular imaging services for accelerated and efficient drug development. We help our clients to reduce the cost and risk of drug development by incorporating preclinical imaging early in the process. In collaboration with our clients we design and conduct tailored molecular imaging protocols to i.e measure drug on target effects, eliminate dead end compounds, and increase the value of lead drug candidates. We facilitate clinical testing and design of adaptive clinical trials using molecular imaging to increase the speed of clinical testing.

Noerre Alle 14 Building 12.3 Copenhagen N, N, DK-2200 DenmarkMinerva Imaging is a contract research organization specializing in molecular imaging services for accelerated and efficient drug development. We help our clients to reduce the cost and risk of drug development by incorporating preclinical imaging early in the process. In collaboration with our clients we design and conduct tailored molecular imaging protocols to i.e measure drug on target effects, eliminate dead end compounds, and increase the value of lead drug candidates. We facilitate clinical testing and design of adaptive clinical trials using molecular imaging to increase the speed of clinical testing.

79 Islands Brygge København, Capital Region of Denmark, 2300 DenmarkN2MO has a technology to measure the penetration of compounds that can pass the blood-brain barrier (BBB), using grasshoppers as a model organism. The target customers are companies with drug discovery projects for the central nervous system (CNS), having compounds they want to get into the brain. The N2MO technology measures the penetration of the BBB using grasshopper as a model organism. The dissected grasshopper brain is submerged in a solution of the test substance. After a given time the concentration of the substance in the brain is measured and the penetration through the BBB is calculated. The major advantage is the use of only small amounts of test substance. It requires amounts you get from a first synthesis. The other advantage is the ethical considerations that limit the use of mammals in drug discovery.

herlev hovedgade 205-207 Herlev, 2730 DenmarkCRO specialized in the development of novel biomarkers and broad diagnostic solutions for pre-clinical and clinical Development with over 20 years of experience; Our service portfolio includes: a) Unique proprietary protein fingerprint biomarkers; b)End-to-end Central laboratory services at our CAP-certified, GCP-compliant lab in the Nordics; c) Assay development, validations, and platform changes; d)Scientific and regulatory consultancy; e)Biobank services; f) pre-clinical ex-vivo models; g) Measurement of biomarkers in translational and pre-clinical external models; Specialist in the following indications: a)Rheumatology and Dermatology; b) Gastro-intestinal and Liver diseases; c) Cardio-vascular and renal diseases; d) Neuro-degenerative diseases; e) Bone and Muscular diseases; f) Oncology, with a focus on solid tumors; g) Respiratory diseases;

Krogshoejvej 36Novozymes Biopharma offers biopharmaceutical manufacturing products and services.

Rønnegade 8 Copenhagen, 2100 DenmarkNuevolution utilizes its proprietary Chemetics technology to synthesize and identify hundreds of diverse drug leads to pharmaceutically important therapeutically targets.

Scheele vägen Lund, Skåne Län, 223 63 SwedenNygen builds CyteType, an AI-powered annotation engine for single-cell and spatial transcriptomics data used in drug discovery pipelines. CyteType delivers reproducible, auditable cell type annotations with ontology-mapped labels, marker-level evidence trails, functional state resolution, and confidence scoring. In preprint benchmarks across 977 clusters and 20 datasets, it outperforms existing methods by up to 388%. Used in: target discovery, biomarker and responder stratification, translational biology, cell therapy characterisation, safety and toxicology, clinical immune monitoring, consortium-scale cell atlas annotation. Data security: Private by default. Zero data retention from LLM providers. Only pseudo-bulk expression data transmitted. No reuse for training or benchmarking. On-premise deployment available. Integration: Python (PyPI), R (CyteTypeR), Scanpy, Seurat. Nygen also offers ScarfWeb, a no-code, browser-based analysis workbench for single-cell and multi-omics data. Built for experimental researchers and core facilities who need to explore, visualise, and collaborate on datasets without writing code. Lund, Sweden. nygen.io Nygen is based in Lund, Sweden.

15 Scheelevägen Skåne län, 22370 SwedenWe are the first startup from the Okinawa Institute of Science and Technology Graduate University (OIST) established on June 25, 2014. The company has grown from advanced structural imaging technology developed by Professor Ulf Skoglund of the OIST Structural Cellular Biology Unit. Based in Onna-son, Okinawa, headed by CEO Akira Kamei, we provide contracted research services worldwide. What we do Okinawa Protein Tomography provides macromolecular imaging service that includes proteins in various states at the single, individual molecule-level by combining conventional electron tomography and a specifically designed 3D reconstruction program known as COMET. The current resolution of a 3D image produced by this technique is approximately 15A and the resolution is steadily improving. The ultimate goal of imaging protein structures is to provide data for new drug design. By utilizing data obtained by the new technology at various stages of the drug development, pharmaceutical companies will be able to analyze drug candidates efficiently and effectively. Thanks to our technology it is now possible: I. Visualization of protein and/or protein complexes and their dynamics, serving as an alternative solution to the study of biological samples that are difficult or impossible to crystallize II.To approach the study of individual proteins as well as protein complexes, revealing properties such as shape, binding domains and flexibility, III. To reveal conformational distribution of flexible molecules, by taking images of individual proteins and protein complexes, IV. Visualization of membrane proteins. It is now the only method that can provide this information, V. To analyze proteins in a variety of contexts

Sollerupvej 28 4681 Herfolge DenmarkOpend is a company supplying unique products, services and solutions to the Life Science Industry.

Hørsholm, 2970 DenmarkParticle Analytical offers particle analytical methods in support of the pharmaceutical industry.

Agern Allé 3Particle Analytical offers particle analytical methods in support of the pharmaceutical industry.

Åstorp, Skåne County SwedenPercell Biolytica specializes in the development, production, and commercialization of CultiSpher macroporous microcarriers.

Ji-Te gatan 9 Åstorp, S-265 38 SwedenPercell Biolytica specializes in the development, production, and commercialization of CultiSpher macroporous microcarriers.

Skaaremosevej 11-14 Blistrup DK- 3230 Græsted DenmarkPersano produces cosmetic and pharmaceutical products.

24 Agern Alle Hørsholm, 2970 DenmarkPharmaLex is a leading provider of specialized services for the pharma, biotech and medical device industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-enabled solutions to support you through the entire product lifecycle. We deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions worldwide.

Kolonivägen 1At PRA Health Sciences, providing innovative solutions for our clients is what we do. But innovation just for the sake of innovation isn’t why we do it. Side-by-side with our clients, we strive to move drug discovery forward, to help them develop life-saving and life- improving drugs. We help change people’s lives for the better every single day. It’s who we are. Innovating to help people is at the heart of our process, but it’s even more than that. It’s also our privilege.

Holmebuen, 4 Karlslunde, Zealand, 2690 DenmarkWe help life science innovators make clearer pricing and access decisions with tailored consulting and purpose-built tools, supporting their journey from early development to launch. At a glance, Pricia offers everything you’d expect from a boutique top-tier pricing and market access partner, from HTA submissions and payer research to IRP modelling and launch strategy. What sets us apart is how we deliver. We combine global expertise with a European base and a strong understanding of US payer dynamics. Every engagement is led by experienced consultants who stay involved from start to finish. We don’t hand projects off — we stay close, move fast and build solutions that reflect each client’s reality. Whether you’re a startup preparing for your first launch or a global pharma refining your access strategy, Pricia offers the hands-on expertise, proprietary tools and a partner network to help you move forward with confidence.

Løngangsstræde 37b Copenhagen, 1468 DenmarkWe help life science innovators make clearer pricing and access decisions with tailored consulting and purpose-built tools, supporting their journey from early development to launch. At a glance, Pricia offers everything you’d expect from a boutique top-tier pricing and market access partner, from HTA submissions and payer research to IRP modelling and launch strategy. What sets us apart is how we deliver. We combine global expertise with a European base and a strong understanding of US payer dynamics. Every engagement is led by experienced consultants who stay involved from start to finish. We don’t hand projects off — we stay close, move fast and build solutions that reflect each client’s reality. Whether you’re a startup preparing for your first launch or a global pharma refining your access strategy, Pricia offers the hands-on expertise, proprietary tools and a partner network to help you move forward with confidence.

Scheelev. 17 Lund, 223 70 SwedenQlucore is a leading provider of new generation intuitive bioinformatics software for research and precision and companion diagnostics. Qlucore’s mission is to make it easier to analyze the huge amounts of complex data generated by innovations in the fields of genomics and proteomics by providing powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics. Qlucore Omics Explorer software is a easy to use bioinformatics software for research in the life science, plant- and biotech industries, as well as in academia. Qlucore Diagnostics and Qlucore Insights are software platforms with built in AI-based machine learning for multi-omics companion and precision diagnostics. Qlucore was founded in 2007 in Lund, Sweden and has customers in about 25 countries around the world, with sales offices in Europe and North America, and distribution in several countries in Asia. Qlucore is listed on the Nasdaq First North Growth market. www.qlucore.com

Agneslundsvägen 27QPharma is a contract developer and manufacturer of pharmaceuticals.

Soldattorpsvägen 5 Limhamn (Malmö) SwedenRechon offers preparation, packaging and distribution of pharmaceuticals.

Medicon Village Lund, SE, 22381 SwedenRedoxis is a Swedish CRO that specializes in in vivo animal models for preclinical drug efficacy validation as well as ex vivo and in vitro models for investigation of MoA. Our main disease models are those of autoimmunity and chronic inflammation where we have both conventional models and cutting-edge developed models. With a focused area of disease models, and an efficient and competent crew of researchers, we provide world-leading studies in a professional manner, with speed, flexibility and high value for the investment. Our major in vivo disease models includes models of *Rheumatoid arthritis ** Mouse collagen-induced arthritis ** Rat collagen-induced arthritis ** Rat Pristane-induced arthritis ** Mouse Collagen Antibody induced arthritis ** Mouse Glucose-6-Phosphate Isomerase induced arthritis ** Rat adoptive T cell transfer *Monoarthritis *Multiple sclerosis ** Rat spinal cord homogenate induced EAE ** Rat MOG1-125 induced EAE ** Rat MBP induced EAE ** Mouse MOG35-55 induced EAE ** Mouse PLP induced EAE *Guillain Barré syndrome *Systemic Lupus ** Spontaneous models ** Induced models *Psoriasis/Psoriasisarthritis ** Imiquimod (IMQ) induced psoriasis in mice ** Mannan induced psoriatic arthritis (MiP) *Acute inflammation sepsis (LPS induced) *Gout *Models of Parkinson´s disease With our fully equipped lab, we can perform most immunology assays and are used to set up and validate new models on-demand with methods including ELISA, Luminex, Flow cytometry, chemotaxis, viability, NOX2 activity. We also routinely perform PK studies, safety studies and organ or sample collections. Redoxis has recently set up a Class II lab for custom-made viral vector studies.

Kanalholmen 1, 2.th. Hvidovre, Hvidovre, 2650 DenmarkRefLab is a CRO and privately held service laboratory with extensive expertise in allergy and chronic spontaneous urticaria diagnostics. We are serving hospitals and allergy/immunology specialists worldwide with our allergy diagnotiscs and drug allergy testing. We also offer preclinical contract research services and clinical sample analysi to commercial and academic partners within allergies and chronic spontanous urticaria through our basophil histamine release assay (BHRA) and human ex vivo skin model. RefLab's laboratory services are ISO 17025 accredited and we are ISO 13485 certified. We offer services as GCLP or non-GCLP.

Marielundvej 25 Herlev​​, 2730 DenmarkCapital region pharmacy of Hovedstadens.

Sheelevägen 8 Lund, 223 63 SwedenRG Discovery is a leading Scandinavian CRO providing premium services within two major areas: Drug Discovery and Analytical Services & Advanced Chemistry. Our expertise and focus are small molecules, macrocycles and peptides. We are based in Lund in the dynamic Medicon Valley region centred around Copenhagen. Integrated Drug Discovery • Expertise in MedChem, computational science, in vitro biology, and ADME/physchem • Experience across target classes and indications • Track record of project deliveries from hit finding to clinical candidates • Fragment-based drug discovery Analytical Services & Advanced Chemistry • Qualitative and quantitative analysis, structure identification, and conformational studies by NMR • Separation services for purification of substances and isolation of impurities including chiral separation • Synthesis of small molecules, peptides, macrocycles, carbohydrates, conjugates & linkers, and polymers • Advanced MS and NMR studies Besides our CRO business, we also perform research project collaborations with various biotech and academic partners. RG Discovery was founded in 2011 as Red Glead Discovery by former Astra Zeneca employees.

Medicon Village, Scheelevagen 8, 223 63 Lund, SwedenRG Discovery is a leading Scandinavian CRO providing premium services within two major areas: Drug Discovery and Analytical Services & Advanced Chemistry. Our expertise and focus are small molecules, macrocycles and peptides. We are based in Lund in the dynamic Medicon Valley region centred around Copenhagen. Integrated Drug Discovery • Expertise in MedChem, computational science, in vitro biology, and ADME/physchem • Experience across target classes and indications • Track record of project deliveries from hit finding to clinical candidates • Fragment-based drug discovery Analytical Services & Advanced Chemistry • Qualitative and quantitative analysis, structure identification, and conformational studies by NMR • Separation services for purification of substances and isolation of impurities including chiral separation • Synthesis of small molecules, peptides, macrocycles, carbohydrates, conjugates & linkers, and polymers • Advanced MS and NMR studies Besides our CRO business, we also perform research project collaborations with various biotech and academic partners. RG Discovery was founded in 2011 as Red Glead Discovery by former Astra Zeneca employees.

8 Scheele vägen Lund, Skåne Län, 223 63 SwedenRG Discovery is a leading Scandinavian CRO providing premium services within two major areas: Drug Discovery and Analytical Services & Advanced Chemistry. Our expertise and focus are small molecules, macrocycles and peptides. We are based in Lund in the dynamic Medicon Valley region centred around Copenhagen. Integrated Drug Discovery • Expertise in MedChem, computational science, in vitro biology, and ADME/physchem • Experience across target classes and indications • Track record of project deliveries from hit finding to clinical candidates • Fragment-based drug discovery Analytical Services & Advanced Chemistry • Qualitative and quantitative analysis, structure identification, and conformational studies by NMR • Separation services for purification of substances and isolation of impurities including chiral separation • Synthesis of small molecules, peptides, macrocycles, carbohydrates, conjugates & linkers, and polymers • Advanced MS and NMR studies Besides our CRO business, we also perform research project collaborations with various biotech and academic partners. RG Discovery was founded in 2011 as Red Glead Discovery by former Astra Zeneca employees.

Fruebjergvej 3 Copenahgen, Capital Region, 2100 DenmarkThroughout the natural world organisms use glycosylation enzymes to adapt molecules for a variety of purposes. Gly-it gives you the ability to copy these processes, allowing you to improve a significant number of important functional properties. We offer a full service focused on achieving the transformations that you need. We can also support you in scaling-up your process. We provide kits and training for you to use the enzymes in your own lab.

Scheelevägen 2, MV406 Lund, SE-22381 SwedenPrecision Cancer Medicine is now. We provide molecular genetic tests and services for healthcare, biopharmaceutical companies, and academia. Based on leading research from Lund University, Sweden, our proprietary and patented molecular genetic tests are part of a revolution in cancer companion diagnostics and monitoring. Our tests quantify circulating tumor DNA (ctDNA) — a powerful new biomarker — to detect cancer, measure response to therapy, and decipher the cancer-specific DNA mutations that may be targetable with clinically-approved drugs or therapies currently in clinical trials. Unique and unprecedented accuracy and sensitivity, with a lower limit of detection that is 10 to 100-fold improved compared to other NGS methods. Our analyses detect what others miss.

Medicon Village Scheelevägen 8, port 402 Lund, 223 63 SwedenSARomics Biostructures is a technology driven research company located in the Medicon Valley region of southern Sweden. Our platform is focused around state-of-the-art industry leading technologies for high-throughput protein crystallization and structure determination, computational chemistry and fragment-based screening. Our expertise in structure-based design is applied to a number of innovative early stage drug discovery projects as well as fee for service projects to clients. Our extensive portfolio of FastLane off-the-shelf protein structures enables faster project execution that substantially accelerates the drug discovery process. Our close proximity to the worlds most advanced synchrotron light source the MAX IV Laboratory provides us with extremely rapid access to synchrotron beamtime, enabling our highly experienced team to deliver results at a competitive price with turn-around times of 2-8 weeks.

Medicon Village Scheelevägen 2 SE-223 63 Lund SwedenSARomics Biostructures is a technology driven research company located in the Medicon Valley region of southern Sweden. Our platform is focused around state-of-the-art industry leading technologies for high-throughput protein crystallization and structure determination, computational chemistry and fragment-based screening. Our expertise in structure-based design is applied to a number of innovative early stage drug discovery projects as well as fee for service projects to clients. Our extensive portfolio of FastLane off-the-shelf protein structures enables faster project execution that substantially accelerates the drug discovery process. Our close proximity to the worlds most advanced synchrotron light source the MAX IV Laboratory provides us with extremely rapid access to synchrotron beamtime, enabling our highly experienced team to deliver results at a competitive price with turn-around times of 2-8 weeks.

Medicon Village Scheelevagen 8, port 402 Lund, 22363 SwedenSARomics Biostructures is a technology driven research company located in the Medicon Valley region of southern Sweden. Our platform is focused around state-of-the-art industry leading technologies for high-throughput protein crystallization and structure determination, computational chemistry and fragment-based screening. Our expertise in structure-based design is applied to a number of innovative early stage drug discovery projects as well as fee for service projects to clients. Our extensive portfolio of FastLane off-the-shelf protein structures enables faster project execution that substantially accelerates the drug discovery process. Our close proximity to the worlds most advanced synchrotron light source the MAX IV Laboratory provides us with extremely rapid access to synchrotron beamtime, enabling our highly experienced team to deliver results at a competitive price with turn-around times of 2-8 weeks.

Medicon Village Scheelevägen 2 Lund, 223 81 SwedenSARomics Biostructures is a technology driven research company located in the Medicon Valley region of southern Sweden. Our platform is focused around state-of-the-art industry leading technologies for high-throughput protein crystallization and structure determination, computational chemistry and fragment-based screening. Our expertise in structure-based design is applied to a number of innovative early stage drug discovery projects as well as fee for service projects to clients. Our extensive portfolio of FastLane off-the-shelf protein structures enables faster project execution that substantially accelerates the drug discovery process. Our close proximity to the worlds most advanced synchrotron light source the MAX IV Laboratory provides us with extremely rapid access to synchrotron beamtime, enabling our highly experienced team to deliver results at a competitive price with turn-around times of 2-8 weeks.

Medicon Village SE-223 81 Lund SwedenSARomics Biostructures is a technology driven research company located in the Medicon Valley region of southern Sweden. Our platform is focused around state-of-the-art industry leading technologies for high-throughput protein crystallization and structure determination, computational chemistry and fragment-based screening. Our expertise in structure-based design is applied to a number of innovative early stage drug discovery projects as well as fee for service projects to clients. Our extensive portfolio of FastLane off-the-shelf protein structures enables faster project execution that substantially accelerates the drug discovery process. Our close proximity to the worlds most advanced synchrotron light source the MAX IV Laboratory provides us with extremely rapid access to synchrotron beamtime, enabling our highly experienced team to deliver results at a competitive price with turn-around times of 2-8 weeks.

Limhamnsvägen Malmö, Skåne län SwedenSaveen Werner provides life science products and instruments.

Energivej 42 Pepparedsleden 3 Ballerup, 2750 DenmarkScantox: Scientific Excellence in Preclinical Research 47+ Years as a Trusted Partner | AAALAC-Accredited | GLP Facilities Scantox is a leading nonclinical CRO with AAALAC-accredited facilities offering integrated discovery-to-IND services. With 47+ years of experience, our nonclinical capabilities span discovery pharmacology, genetic and regulatory toxicology, pharmaceutical development, and bioanalysis. With direct access to senior scientists and a commitment to scientific excellence, we serve as a trusted partner to pharmaceutical, biotech and medical device companies. Our comprehensive services enable clients to seamlessly advance drug and device development, delivering consistent, high-quality data to the highest technical and scientific standards. Key Differentiators • AAALAC-Accredited Animal Welfare & Technical Excellence – Excellence in animal care with first-in-class indoor/outdoor facilities, complemented by highly tenured technical staff holding 4-year related degrees for exceptional study consistency • Göttingen Minipig Center of Excellence – Industry-leading expertise in large animal safety studies with dedicated facilities and specialized staff trained in large animal research methodologies • Specialized Neuropharmacology Capabilities – Advanced CNS disease models and rare disease expertise spanning neurological research with sophisticated behavioral and physiological endpoints • ESG Leadership – Commitment to sustainable business practices reflected with EcoVadis Bronze Medal in 2025 Core Services • Discovery Pharmacology – In vitro and in vivo model expertise with specialization in CNS neuropharmacology therapeutics, rare neurodegenerative diseases, and comprehensive pharmacological profiling • Regulatory Toxicology – Exploratory tox, TK and PK/PD studies as well as GLP IND-enabling safety studies. General toxicology, juvenile and reproductive toxicology. Extensive experience in rodent and non-rodent species. Standard routes of admin: Oral (via gavage or using capsules/tablets), dermal, intramuscular, subcutaneous, and intravenous. Non-standard routes: Topical to the eye, intravitreal, intraperitoneal, and rectal • Genetic Toxicology – Regulatory genotoxicity assessments, early screening and evaluation • Pharmaceutical Development – Formulation development and dose formulation manufacturing with complete logistics support for Phase 1 and 2 clinical trials • Bioanalytical Services [LC-MS/MS platforms] – Method development, validation, and sample analysis for all study phases Service Details Discovery Pharmacology [Neuropharmacology expertise] Comprehensive pharmacological profiling with specialized expertise in CNS diseases, rare diseases, and mental disorders through our neuropharmacology division. Advanced disease models and screening platforms support mechanism of action studies, efficacy assessments, and dose-response characterizations across therapeutic areas with integrated PK/PD analysis. Regulatory Toxicology [Göttingen Minipig leadership] Full spectrum of GLP-compliant preclinical toxicology studies with recognized leadership in Göttingen Minipig safety assessments. Our operational depth covers anesthesia protocols, dosing procedures, sampling techniques, and endpoint assessments with robust historical control databases. Comprehensive capabilities include acute and chronic toxicity, carcinogenicity, reproductive and developmental toxicology, immunotoxicology, and safety pharmacology evaluations across diverse species selection. Genetic Toxicology [Complete screening battery] Comprehensive portfolio of screening and regulatory genotoxicity services including bacterial reverse mutation (Ames), mammalian cell gene mutation studies, chromosome aberration tests, and micronucleus assays. Specialized assessment of photosensitivity potential with clear regulatory pathway guidance. Pharmaceutical Development [Formulation and clinical support] Formulation development and dose formulation manufacturing with complete logistics support for Phase 1 and 2 clinical trials. Services span from traditional small molecules through complex biologics, ensuring seamless progression from preclinical development through early clinical phases. Bioanalytical Services [LC-MS/MS platforms] Comprehensive LC-MS/MS method development, validation, and sample analysis for exploratory, regulatory, and clinical studies. Full-service capabilities include handling of complex compounds and controlled substances with established quality systems for global regulatory compliance. Integrated Service Platform Our multidisciplinary approach from discovery pharmacology through regulatory submission enables clients to progress development projects with consistent quality standards and streamlined communication. Multidisciplinary teams coordinate across pharmacology, toxicology, pathology, formulation, and bioanalysis with unified project management.

Energivej 42 Ballerup, 2750 DenmarkScantox: Scientific Excellence in Preclinical Research 47+ Years as a Trusted Partner | AAALAC-Accredited | GLP Facilities Scantox is a leading nonclinical CRO with AAALAC-accredited facilities offering integrated discovery-to-IND services. With 47+ years of experience, our nonclinical capabilities span discovery pharmacology, genetic and regulatory toxicology, pharmaceutical development, and bioanalysis. With direct access to senior scientists and a commitment to scientific excellence, we serve as a trusted partner to pharmaceutical, biotech and medical device companies. Our comprehensive services enable clients to seamlessly advance drug and device development, delivering consistent, high-quality data to the highest technical and scientific standards. Key Differentiators • AAALAC-Accredited Animal Welfare & Technical Excellence – Excellence in animal care with first-in-class indoor/outdoor facilities, complemented by highly tenured technical staff holding 4-year related degrees for exceptional study consistency • Göttingen Minipig Center of Excellence – Industry-leading expertise in large animal safety studies with dedicated facilities and specialized staff trained in large animal research methodologies • Specialized Neuropharmacology Capabilities – Advanced CNS disease models and rare disease expertise spanning neurological research with sophisticated behavioral and physiological endpoints • ESG Leadership – Commitment to sustainable business practices reflected with EcoVadis Bronze Medal in 2025 Core Services • Discovery Pharmacology – In vitro and in vivo model expertise with specialization in CNS neuropharmacology therapeutics, rare neurodegenerative diseases, and comprehensive pharmacological profiling • Regulatory Toxicology – Exploratory tox, TK and PK/PD studies as well as GLP IND-enabling safety studies. General toxicology, juvenile and reproductive toxicology. Extensive experience in rodent and non-rodent species. Standard routes of admin: Oral (via gavage or using capsules/tablets), dermal, intramuscular, subcutaneous, and intravenous. Non-standard routes: Topical to the eye, intravitreal, intraperitoneal, and rectal • Genetic Toxicology – Regulatory genotoxicity assessments, early screening and evaluation • Pharmaceutical Development – Formulation development and dose formulation manufacturing with complete logistics support for Phase 1 and 2 clinical trials • Bioanalytical Services [LC-MS/MS platforms] – Method development, validation, and sample analysis for all study phases Service Details Discovery Pharmacology [Neuropharmacology expertise] Comprehensive pharmacological profiling with specialized expertise in CNS diseases, rare diseases, and mental disorders through our neuropharmacology division. Advanced disease models and screening platforms support mechanism of action studies, efficacy assessments, and dose-response characterizations across therapeutic areas with integrated PK/PD analysis. Regulatory Toxicology [Göttingen Minipig leadership] Full spectrum of GLP-compliant preclinical toxicology studies with recognized leadership in Göttingen Minipig safety assessments. Our operational depth covers anesthesia protocols, dosing procedures, sampling techniques, and endpoint assessments with robust historical control databases. Comprehensive capabilities include acute and chronic toxicity, carcinogenicity, reproductive and developmental toxicology, immunotoxicology, and safety pharmacology evaluations across diverse species selection. Genetic Toxicology [Complete screening battery] Comprehensive portfolio of screening and regulatory genotoxicity services including bacterial reverse mutation (Ames), mammalian cell gene mutation studies, chromosome aberration tests, and micronucleus assays. Specialized assessment of photosensitivity potential with clear regulatory pathway guidance. Pharmaceutical Development [Formulation and clinical support] Formulation development and dose formulation manufacturing with complete logistics support for Phase 1 and 2 clinical trials. Services span from traditional small molecules through complex biologics, ensuring seamless progression from preclinical development through early clinical phases. Bioanalytical Services [LC-MS/MS platforms] Comprehensive LC-MS/MS method development, validation, and sample analysis for exploratory, regulatory, and clinical studies. Full-service capabilities include handling of complex compounds and controlled substances with established quality systems for global regulatory compliance. Integrated Service Platform Our multidisciplinary approach from discovery pharmacology through regulatory submission enables clients to progress development projects with consistent quality standards and streamlined communication. Multidisciplinary teams coordinate across pharmacology, toxicology, pathology, formulation, and bioanalysis with unified project management.

Medicon Village Sheelevägen 2 Lund, 223 63 SwedenScantox: Scientific Excellence in Preclinical Research 47+ Years as a Trusted Partner | AAALAC-Accredited | GLP Facilities Scantox is a leading nonclinical CRO with AAALAC-accredited facilities offering integrated discovery-to-IND services. With 47+ years of experience, our nonclinical capabilities span discovery pharmacology, genetic and regulatory toxicology, pharmaceutical development, and bioanalysis. With direct access to senior scientists and a commitment to scientific excellence, we serve as a trusted partner to pharmaceutical, biotech and medical device companies. Our comprehensive services enable clients to seamlessly advance drug and device development, delivering consistent, high-quality data to the highest technical and scientific standards. Key Differentiators • AAALAC-Accredited Animal Welfare & Technical Excellence – Excellence in animal care with first-in-class indoor/outdoor facilities, complemented by highly tenured technical staff holding 4-year related degrees for exceptional study consistency • Göttingen Minipig Center of Excellence – Industry-leading expertise in large animal safety studies with dedicated facilities and specialized staff trained in large animal research methodologies • Specialized Neuropharmacology Capabilities – Advanced CNS disease models and rare disease expertise spanning neurological research with sophisticated behavioral and physiological endpoints • ESG Leadership – Commitment to sustainable business practices reflected with EcoVadis Bronze Medal in 2025 Core Services • Discovery Pharmacology – In vitro and in vivo model expertise with specialization in CNS neuropharmacology therapeutics, rare neurodegenerative diseases, and comprehensive pharmacological profiling • Regulatory Toxicology – Exploratory tox, TK and PK/PD studies as well as GLP IND-enabling safety studies. General toxicology, juvenile and reproductive toxicology. Extensive experience in rodent and non-rodent species. Standard routes of admin: Oral (via gavage or using capsules/tablets), dermal, intramuscular, subcutaneous, and intravenous. Non-standard routes: Topical to the eye, intravitreal, intraperitoneal, and rectal • Genetic Toxicology – Regulatory genotoxicity assessments, early screening and evaluation • Pharmaceutical Development – Formulation development and dose formulation manufacturing with complete logistics support for Phase 1 and 2 clinical trials • Bioanalytical Services [LC-MS/MS platforms] – Method development, validation, and sample analysis for all study phases Service Details Discovery Pharmacology [Neuropharmacology expertise] Comprehensive pharmacological profiling with specialized expertise in CNS diseases, rare diseases, and mental disorders through our neuropharmacology division. Advanced disease models and screening platforms support mechanism of action studies, efficacy assessments, and dose-response characterizations across therapeutic areas with integrated PK/PD analysis. Regulatory Toxicology [Göttingen Minipig leadership] Full spectrum of GLP-compliant preclinical toxicology studies with recognized leadership in Göttingen Minipig safety assessments. Our operational depth covers anesthesia protocols, dosing procedures, sampling techniques, and endpoint assessments with robust historical control databases. Comprehensive capabilities include acute and chronic toxicity, carcinogenicity, reproductive and developmental toxicology, immunotoxicology, and safety pharmacology evaluations across diverse species selection. Genetic Toxicology [Complete screening battery] Comprehensive portfolio of screening and regulatory genotoxicity services including bacterial reverse mutation (Ames), mammalian cell gene mutation studies, chromosome aberration tests, and micronucleus assays. Specialized assessment of photosensitivity potential with clear regulatory pathway guidance. Pharmaceutical Development [Formulation and clinical support] Formulation development and dose formulation manufacturing with complete logistics support for Phase 1 and 2 clinical trials. Services span from traditional small molecules through complex biologics, ensuring seamless progression from preclinical development through early clinical phases. Bioanalytical Services [LC-MS/MS platforms] Comprehensive LC-MS/MS method development, validation, and sample analysis for exploratory, regulatory, and clinical studies. Full-service capabilities include handling of complex compounds and controlled substances with established quality systems for global regulatory compliance. Integrated Service Platform Our multidisciplinary approach from discovery pharmacology through regulatory submission enables clients to progress development projects with consistent quality standards and streamlined communication. Multidisciplinary teams coordinate across pharmacology, toxicology, pathology, formulation, and bioanalysis with unified project management.

Hestehavevej 36A, Ejby Lille Skensved, 4623 DenmarkScantox: Scientific Excellence in Preclinical Research 47+ Years as a Trusted Partner | AAALAC-Accredited | GLP Facilities Scantox is a leading nonclinical CRO with AAALAC-accredited facilities offering integrated discovery-to-IND services. With 47+ years of experience, our nonclinical capabilities span discovery pharmacology, genetic and regulatory toxicology, pharmaceutical development, and bioanalysis. With direct access to senior scientists and a commitment to scientific excellence, we serve as a trusted partner to pharmaceutical, biotech and medical device companies. Our comprehensive services enable clients to seamlessly advance drug and device development, delivering consistent, high-quality data to the highest technical and scientific standards. Key Differentiators • AAALAC-Accredited Animal Welfare & Technical Excellence – Excellence in animal care with first-in-class indoor/outdoor facilities, complemented by highly tenured technical staff holding 4-year related degrees for exceptional study consistency • Göttingen Minipig Center of Excellence – Industry-leading expertise in large animal safety studies with dedicated facilities and specialized staff trained in large animal research methodologies • Specialized Neuropharmacology Capabilities – Advanced CNS disease models and rare disease expertise spanning neurological research with sophisticated behavioral and physiological endpoints • ESG Leadership – Commitment to sustainable business practices reflected with EcoVadis Bronze Medal in 2025 Core Services • Discovery Pharmacology – In vitro and in vivo model expertise with specialization in CNS neuropharmacology therapeutics, rare neurodegenerative diseases, and comprehensive pharmacological profiling • Regulatory Toxicology – Exploratory tox, TK and PK/PD studies as well as GLP IND-enabling safety studies. General toxicology, juvenile and reproductive toxicology. Extensive experience in rodent and non-rodent species. Standard routes of admin: Oral (via gavage or using capsules/tablets), dermal, intramuscular, subcutaneous, and intravenous. Non-standard routes: Topical to the eye, intravitreal, intraperitoneal, and rectal • Genetic Toxicology – Regulatory genotoxicity assessments, early screening and evaluation • Pharmaceutical Development – Formulation development and dose formulation manufacturing with complete logistics support for Phase 1 and 2 clinical trials • Bioanalytical Services [LC-MS/MS platforms] – Method development, validation, and sample analysis for all study phases Service Details Discovery Pharmacology [Neuropharmacology expertise] Comprehensive pharmacological profiling with specialized expertise in CNS diseases, rare diseases, and mental disorders through our neuropharmacology division. Advanced disease models and screening platforms support mechanism of action studies, efficacy assessments, and dose-response characterizations across therapeutic areas with integrated PK/PD analysis. Regulatory Toxicology [Göttingen Minipig leadership] Full spectrum of GLP-compliant preclinical toxicology studies with recognized leadership in Göttingen Minipig safety assessments. Our operational depth covers anesthesia protocols, dosing procedures, sampling techniques, and endpoint assessments with robust historical control databases. Comprehensive capabilities include acute and chronic toxicity, carcinogenicity, reproductive and developmental toxicology, immunotoxicology, and safety pharmacology evaluations across diverse species selection. Genetic Toxicology [Complete screening battery] Comprehensive portfolio of screening and regulatory genotoxicity services including bacterial reverse mutation (Ames), mammalian cell gene mutation studies, chromosome aberration tests, and micronucleus assays. Specialized assessment of photosensitivity potential with clear regulatory pathway guidance. Pharmaceutical Development [Formulation and clinical support] Formulation development and dose formulation manufacturing with complete logistics support for Phase 1 and 2 clinical trials. Services span from traditional small molecules through complex biologics, ensuring seamless progression from preclinical development through early clinical phases. Bioanalytical Services [LC-MS/MS platforms] Comprehensive LC-MS/MS method development, validation, and sample analysis for exploratory, regulatory, and clinical studies. Full-service capabilities include handling of complex compounds and controlled substances with established quality systems for global regulatory compliance. Integrated Service Platform Our multidisciplinary approach from discovery pharmacology through regulatory submission enables clients to progress development projects with consistent quality standards and streamlined communication. Multidisciplinary teams coordinate across pharmacology, toxicology, pathology, formulation, and bioanalysis with unified project management.

Lerso Parkalle 42.6 København Ø, 2100 DenmarkCustom peptide synthesis and high-density peptide arrays. Schafer-N is a Danish company with more than 25 years experience in custom peptide synthesis. We are partners in several multinational research projects in the fields of peptide chemistry, immunology and biomedical engineering. Peptide synthesis is our main business. We have perfected our custom peptide synthesis techniques to a level where more than 95% of peptides ordered from us are successfully produced and shipped within 2 weeks. Peptides are shipped world-wide by courier and with a 30-day money back guarantee. Our prices are very competitive and we back you up with free expert assistance on any problems you may have with handling or design of your peptides. To order peptides or to make requests on peptide syntheses, simply email us or use the contact form in this website. With us you get a personal service from competent staff only and we respond quickly to any inquiries you may send us. We only use proprietary peptide synthesizers and preparative chromatography systems and can handle more than 150 parallel syntheses on the 10-500 mg scale. We do not import peptides from 3rd party manufacturers. We designed all our software systems for peptide synthesis and interpretation of LC-MS analyses. We have completed construction of high-density peptide array synthesizers able to synthesize hundreds of thousands of peptides on a microscope slide. The peptide sequences can be freely defined by you. With this technique we can reduce the cost to less than a cent per peptide. Even within a limited budget this makes it possible for you to screen all n-mer peptides from hundreds of proteins for binding of antibodies and other peptide ligands.

Ringager 4 A, DK-2605 Brøndby, Copenhagen, DenmarkSmerud Medical Research offers clinical research services including trial management, project funding, data management, regulatory affairs, and quality assurance.

Medicon Village Lund, Skåne län, 22381 SwedenSOLVE is a contract analytical lab, helping customers all around the world with AF4-MALS, SEC-MALS, and DLS analysis and method development. Contact us for protein and peptide aggregation, particle size, molecular weight, zeta potential, stability testing, screenings, critical micelle concentration determination, rheological properties. With AF4-MALS we can monitor, for example, antibodies or other biologics in blood serum and blood plasma.

5 ArtillerivejSSI has developed experimental infection models for the purpose of evaluating antimicrobial drugs. These models are ideal for efficacy screening of new compounds in the discovery phase, proof of concept, as well as for pharmacokinetic and pharmacodynamic studies. Advanced mathematical PK/PD modeling is also used as an integrated part of such studies.

Copenhagen DenmarkSSI has developed experimental infection models for the purpose of evaluating antimicrobial drugs. These models are ideal for efficacy screening of new compounds in the discovery phase, proof of concept, as well as for pharmacokinetic and pharmacodynamic studies. Advanced mathematical PK/PD modeling is also used as an integrated part of such studies.

Artillerivej 5 Copenhagen, Capital Region of Denmark, 2300 S DenmarkSSI has developed experimental infection models for the purpose of evaluating antimicrobial drugs. These models are ideal for efficacy screening of new compounds in the discovery phase, proof of concept, as well as for pharmacokinetic and pharmacodynamic studies. Advanced mathematical PK/PD modeling is also used as an integrated part of such studies.

Lundavägen 151 Malmö, 212 24 SwedenSvar Life Science is a Swedish group of companies that invents, develops, and applies the best assay technology for drug development and clinical diagnostics with the goal of delivering new solutions tailored to customer requirements. Our multiple locations worldwide and experience in assay development, bioanalysis, and clinical diagnostics make us an ideal partner for pharma, biotech, and CROs. Svar Life Science offers a comprehensive portfolio of products and solutions: ● Functional and biomarker assays that can be used to explore every angle of complement system-involved in a wide range of application areas. ●The iLite® cell-based solutions that are based on the iLite technology, a cleverly engineered cell-based assay system with a dual reporter gene readout. ●Cell-based custom development services including an assay-ready cell service and master cell bank development. ●CRO Services include Bioanalytical Services, Biomarker Discovery Services, and GMP QC Testing Services. Our GMP, GCP, GLP, and ISO 15189-compliant laboratory is designed to offer assay development, validation, and sample analysis for pre-clinical as well as clinical studies. We have experience with various immunoassays including ELISA, MSD, SIMOA, Olink Proteomics technology, and cell-based assays. We work to deliver the right answers at the right time to improve patient care and accelerate drug development. Our subsidiary: ●Wieslab is our diagnostic laboratory services offering a comprehensive range of clinical diagnostic tests within neuro-immunology, nephrology, rheumatology, and gastroenterology for clinicians and laboratories worldwide.

151 Lundvagen Malmo, 20211 SwedenSvar Life Science is a Swedish group of companies that invents, develops, and applies the best assay technology for drug development and clinical diagnostics with the goal of delivering new solutions tailored to customer requirements. Our multiple locations worldwide and experience in assay development, bioanalysis, and clinical diagnostics make us an ideal partner for pharma, biotech, and CROs. Svar Life Science offers a comprehensive portfolio of products and solutions: ● Functional and biomarker assays that can be used to explore every angle of complement system-involved in a wide range of application areas. ●The iLite® cell-based solutions that are based on the iLite technology, a cleverly engineered cell-based assay system with a dual reporter gene readout. ●Cell-based custom development services including an assay-ready cell service and master cell bank development. ●CRO Services include Bioanalytical Services, Biomarker Discovery Services, and GMP QC Testing Services. Our GMP, GCP, GLP, and ISO 15189-compliant laboratory is designed to offer assay development, validation, and sample analysis for pre-clinical as well as clinical studies. We have experience with various immunoassays including ELISA, MSD, SIMOA, Olink Proteomics technology, and cell-based assays. We work to deliver the right answers at the right time to improve patient care and accelerate drug development. Our subsidiary: ●Wieslab is our diagnostic laboratory services offering a comprehensive range of clinical diagnostic tests within neuro-immunology, nephrology, rheumatology, and gastroenterology for clinicians and laboratories worldwide.

151 Lundavägen Skåne län, 212 24 SwedenSvar Life Science is a Swedish group of companies that invents, develops, and applies the best assay technology for drug development and clinical diagnostics with the goal of delivering new solutions tailored to customer requirements. Our multiple locations worldwide and experience in assay development, bioanalysis, and clinical diagnostics make us an ideal partner for pharma, biotech, and CROs. Svar Life Science offers a comprehensive portfolio of products and solutions: ● Functional and biomarker assays that can be used to explore every angle of complement system-involved in a wide range of application areas. ●The iLite® cell-based solutions that are based on the iLite technology, a cleverly engineered cell-based assay system with a dual reporter gene readout. ●Cell-based custom development services including an assay-ready cell service and master cell bank development. ●CRO Services include Bioanalytical Services, Biomarker Discovery Services, and GMP QC Testing Services. Our GMP, GCP, GLP, and ISO 15189-compliant laboratory is designed to offer assay development, validation, and sample analysis for pre-clinical as well as clinical studies. We have experience with various immunoassays including ELISA, MSD, SIMOA, Olink Proteomics technology, and cell-based assays. We work to deliver the right answers at the right time to improve patient care and accelerate drug development. Our subsidiary: ●Wieslab is our diagnostic laboratory services offering a comprehensive range of clinical diagnostic tests within neuro-immunology, nephrology, rheumatology, and gastroenterology for clinicians and laboratories worldwide.

Lundavägen 151 Malmö, Skane, 212 24 SwedenSvar Life Science is a Swedish group of companies that invents, develops, and applies the best assay technology for drug development and clinical diagnostics with the goal of delivering new solutions tailored to customer requirements. Our multiple locations worldwide and experience in assay development, bioanalysis, and clinical diagnostics make us an ideal partner for pharma, biotech, and CROs. Svar Life Science offers a comprehensive portfolio of products and solutions: ● Functional and biomarker assays that can be used to explore every angle of complement system-involved in a wide range of application areas. ●The iLite® cell-based solutions that are based on the iLite technology, a cleverly engineered cell-based assay system with a dual reporter gene readout. ●Cell-based custom development services including an assay-ready cell service and master cell bank development. ●CRO Services include Bioanalytical Services, Biomarker Discovery Services, and GMP QC Testing Services. Our GMP, GCP, GLP, and ISO 15189-compliant laboratory is designed to offer assay development, validation, and sample analysis for pre-clinical as well as clinical studies. We have experience with various immunoassays including ELISA, MSD, SIMOA, Olink Proteomics technology, and cell-based assays. We work to deliver the right answers at the right time to improve patient care and accelerate drug development. Our subsidiary: ●Wieslab is our diagnostic laboratory services offering a comprehensive range of clinical diagnostic tests within neuro-immunology, nephrology, rheumatology, and gastroenterology for clinicians and laboratories worldwide.

Regionalt biobankscentrum Södra sjukvårdsregionen Scheelevägen 8 223 81 Lund Sweden

Elektrovej Building 375Symphogen develops recombinant antibody mixtures, a new class of antibody therapeutics for the treatment or prophylaxis of serious human diseases.

Tornbjergvej 40, Ejby Lille Skensved, 4623 DenmarkTaconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic helps biotechnology companies and institutions acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.

Dalbyvej 48Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic helps biotechnology companies and institutions acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.

Tornbjergvej 40Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic helps biotechnology companies and institutions acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.

Frederiksberg DenmarkTAG Copenhagen, established in 1996 by Jakob Ross-Petersen, is a first-in-class provider of oligonucleotides across Europe. Furthermore, we are a leading distributor of peptides, antibodies, DNA isolation kits, PCR/qPCR reagents and much more. The past 16 years, we have sold thousands of custom peptides to universities, hospitals and pharma/biotech companies across Europe.

Jernbanegade 23 Roskilde, 4000 Denmarktebubio is a leading European distributor of innovative life science research reagents and lab services. Our extensive network of local offices and sales representatives spanning 9 countries daily assists researchers from universities, pharma, cosmetic and biotech companies in choosing and optimally using the products suited to their research programs . For almost 20 years now, tebu-bio’s own laboratories provide R&D contract services and are an active member of recognized professional networks and clusters (Medicen, Cosmetic Valley... Lab services: tebu-bio ISO9001 certified laboratory possesses 4 major platforms: Biomarkers, Protein Production, Molecular Biology and Cell culture. Biomarkers services: tebu bio provides protein quantification and profiling services, gene and miRNA profiling. For protein quantification, the offer includes quantitative measurement of multiple cytokines, chemokines, adipokines, MMPs... in a wide variety of sample types (cell/tissue lysates, serum/plasma, cell culture supernatants...) on robust assays: antibody array or multiplex ELISA format. In addition, we provide one stop pathway focused or broad profiling services including both sample processing and data analysis. If you don't have the expertise or resources to process array data, tebu-bio's biostatistics and bioinformatics partners can do this for you and provide a full report (heat map, cluster and pathway analysis, biomarker selection...). Application examples: inflammation, apoptosis, obesity biomarker monitoring, signalling pathway identification with broad profiling phosphorylation arrays, glycans or glycan/protein interactions detection, miRNA/gene expression profiling... Human Biological samples & Prospective collections: tebu-bio holds an import/export/handling/storage HBS permit and strictly follows regulatory and ethics guidelines related to human biospecimens collection. -Healthy and Diseased blood derived samples (whole blood, plasma, serum, buffy coat, PBMC, platelets...). -Any type of biofluids -Fresh or frozen tissues, healthy or diseased with mutation characterization possibilities -Broad Primary cells offer (healthy or diseased): Human cryo-preserved Hepatocytes, individual donors or pools, Human Hepatic Stellate Cells, Human dermal fibroblast and keratinocytes, Fresh pancreatic human Islets, Human pre-adipocytes, Human Mesenchymal Stem Cells, Peripheral Blood Mononulear Cells (PBMCs), Peripheral Blood Monocytes CD14+, Bone marrow derived CD34+ cells, Tenocytes, Chondrocytes and Synoviocytes, Primary cells from Lung, kidney, Intestine tissues, iPSC derived cardiomyocytes, iPSC derived neurons. Ready to use QC tested specialized media for every primary cell type. Now tebu-bio is the exclusive European distributor of Japanese Collection of Research Bioresources Cell Bank (JCRB), which is one of the most comprehensive cell banks (more than 1 300 cell lines) for Life Scientists and collects high quality cell lines from numerous species such as animal and humans including cancer and genetically modified cells. Protein production (E. coli, HEK293) : tebu-bio provides services from A to Z: gene synthesis, cloning, small scale protein expression to optimize production conditions, large production batches. Our experts have extensive experience and expertise in protein purification and characterization, they will accompany you all along your project. Other services: cell biology (cell amplification & differentiation, cell-line engineering, Spheroids production...); 3D cell culture; hypoxia and normoxia culture conditions; molecular biology, bio-assays (gene reporter & nuclear receptor assays, outsourcing of any assays commercialised by tebu-bio...) Products offer: research antibodies, ELISAs, arrays, proteins & peptides, cell-based & functional assays, primary cells & media (incl. cytokines and growth factors), stem cells and iPS cells, characterized cell lines (ex. melanoma, brain- and stem-cell derived, cell line engineering tools (si/shRNA,CRISPR), biochemicals & compounds, functional assays (actin, tubulin, lipid research tools...).

Ruben Rausings gata 11 BTrial Form Support (TFS) offers phase 0-IV clinical research services including clinical operations, data management, regulatory affairfs, quality assurance, and drug safety.

2 Scheelevägen Skåne län, 223 63 SwedenTimeline Bioresearch offers preclinical in vivo studies in rodent models and large animal models including rabbit, and pigs.

Vallensbækvej 35 Brøndby, 2605 DenmarkTriolab AS is a professional sales organization founded in 1991. We specialize in the import, marketing, sales, and technical support of IVD products. Due to our extensive product range and long experience in the field of clinical diagnostics, we have customers in all healthcare segments, and also veterinary institutions, pharmaceutical companies, and special university labs are among our customers. Our skillful and highly committed personnel has a deep understanding of the market and our customers'​ needs, and they always meet our customers with an open mind, a friendly attitude, and a strong desire to find the best possible solution for each individual customer. We have sister companies in Norway, Sweden, and Finland, and together we are one of the leading suppliers of IVD products in the Nordic area. Triolab AS is part of AddLife, a Swedish group specialized in selected niches within diagnostics, medical technology, biomedical research and laboratory analysis (www.add.life). AddLife is quoted on the NASDAQ Stockholm Main Market.

Godsmottagningen Scheelevägen 8 Lund, Skåne, SE-223 63 SwedenTruly Labs is preclinical CRO working to support customers within the drug development area. We provide in vitro as well as in vivo lab services in combination with senior strategic and regulatory advice. We are located at Medicon Village in Lund Sweden and at Novum in Huddinge.

Medicon Village Lund, Skåne, 22381 SwedenTruly Labs is preclinical CRO working to support customers within the drug development area. We provide in vitro as well as in vivo lab services in combination with senior strategic and regulatory advice. We are located at Medicon Village in Lund Sweden and at Novum in Huddinge.

Lund, Skåne County SwedenTruly Translational provides life science and drug development consultancy with an emphasis on biology and translational science.

Nygaardsvej 32 Copenhagen O, 2100 DenmarkUnilabs Pharma Solutions is a network of specialist laboratories providing DMPK, bioanalysis, and biomarker services that support pharmaceutical development from late-stage discovery through clinical trials and post-market studies. With laboratories in York and Sandwich (UK) and Copenhagen (Denmark), we work with pharmaceutical companies, biotech firms, CROs, and healthcare organisations worldwide, delivering tailored, scalable analytical solutions backed by scientific expertise, agile project management, and strong regulatory knowledge. Our Copenhagen laboratory specializes in bioanalytical and molecular biology services, focusing on large molecule bioanalysis and biomarker discovery and validation. Through the development and validation of robust analytical methods, we generate precise, reproducible, and regulatory-ready data for preclinical and clinical programs. Our capabilities include molecular biology, large molecule bioanalysis, and biomarker research, supported by techniques such as qPCR/RT-qPCR, ELISA and MSD immunoassays, enzymatic and fluorescence-based assays, PBMC isolation and cell purification workflows, and coagulation assays. By combining validated workflows, rapid turnaround, and decades of scientific experience, we support everything from early discovery screening to complex late-stage studies, helping accelerate drug development and improve patient outcomes through reliable, high-quality data.

32 Nygårdsvej København, 2100 DenmarkUnilabs Pharma Solutions is a network of specialist laboratories providing DMPK, bioanalysis, and biomarker services that support pharmaceutical development from late-stage discovery through clinical trials and post-market studies. With laboratories in York and Sandwich (UK) and Copenhagen (Denmark), we work with pharmaceutical companies, biotech firms, CROs, and healthcare organisations worldwide, delivering tailored, scalable analytical solutions backed by scientific expertise, agile project management, and strong regulatory knowledge. Our Copenhagen laboratory specializes in bioanalytical and molecular biology services, focusing on large molecule bioanalysis and biomarker discovery and validation. Through the development and validation of robust analytical methods, we generate precise, reproducible, and regulatory-ready data for preclinical and clinical programs. Our capabilities include molecular biology, large molecule bioanalysis, and biomarker research, supported by techniques such as qPCR/RT-qPCR, ELISA and MSD immunoassays, enzymatic and fluorescence-based assays, PBMC isolation and cell purification workflows, and coagulation assays. By combining validated workflows, rapid turnaround, and decades of scientific experience, we support everything from early discovery screening to complex late-stage studies, helping accelerate drug development and improve patient outcomes through reliable, high-quality data.

3B Blegdamsvej København, 2200 Denmark

Copenhagen, Capital Region of Denmark DenmarkProtein Science Facility comprises of two independent organisational units: Protein Production Facility Protein Function and Interactions group Both units are headed by Associate Professor, Mats Wikström and operate within the fields of protein production (1) and research focused on understanding molecular recognition through biophysical and structural studies of protein-protein interactions applied to systems of biomedical importance (2).

215 Nordre Fasanvej Frederiksberg, 2000 DenmarkVibraint ApS is a cutting-edge deep-tech company specialising in neuroscience. The name Vibraint, derived from virtual brain technologies, reflects our focus on advanced whole-brain imaging, AI-driven analysis and immersive data visualisation of rodent brains. We empower neuroscientists in academia, biotech and pharma with high-precision imaging services and powerful analytical tools that accelerate brain research. Our unique virtual brain viewer enables intuitive exploration of complex datasets and seamless integration of multimodal data from multiple sources. By combining artificial intelligence, data mining and interactive visualisation, Vibraint is transforming how brain diseases are understood and how next-generation therapeutics are developed.

Gammel Kongevej 23A, 1st floor DK-1610 Copenhagen DenmarkVipergen is a world leading provider of small molecule drug discovery services based on DNA-encoded library (DEL) technologies.

24 Agern Alle Hørsholm, 2970 DenmarkVisiopharm is a world leader in Augmented Pathology™ solutions. Leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, and hospital diagnostic pathology labs all over the world utilize the Visiopharm software platform for tissue-based research and diagnostics. The software provides scientists and pathologist with a scalable solution that fits the needs and volumes of both research and diagnostic labs. Over the past 16 years Visiopharm has grown into an international business with over 800 installations and countless more users. Visiopharm software is featured in over 1500 scientific publications since 2010 and is compatible with leading slide scanning systems and data management software. A growing network of authorized distributors and integration partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Our headquarters is in the Medicon Valley of Denmark, with a branch office in the United Kingdom, and a North American office in Broomfield, Colorado.

Agern Alle 24 Hoersholm, DK- DenmarkVisiopharm is a world leader in Augmented Pathology™ solutions. Leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, and hospital diagnostic pathology labs all over the world utilize the Visiopharm software platform for tissue-based research and diagnostics. The software provides scientists and pathologist with a scalable solution that fits the needs and volumes of both research and diagnostic labs. Over the past 16 years Visiopharm has grown into an international business with over 800 installations and countless more users. Visiopharm software is featured in over 1500 scientific publications since 2010 and is compatible with leading slide scanning systems and data management software. A growing network of authorized distributors and integration partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Our headquarters is in the Medicon Valley of Denmark, with a branch office in the United Kingdom, and a North American office in Broomfield, Colorado.

Ole Maaløes Vej 3 Copenhagen, 2200 DenmarkXenia Pharma is a private independent consultancy company with focus on preclinical and veterinary pharmacology.

Copenhagen DenmarkXenia Pharma is a private independent consultancy company with focus on preclinical and veterinary pharmacology.

Sankt Lars väg 45 B, SE-222 70 Lund, SwedenZelmic focuses on the development of new products for local or topical delivery.

Lund, Skåne County SwedenZelmic focuses on the development of new products for local or topical delivery.

Fruebjergvej 3 Copenhagen, 2100 DenmarkZerion Pharma is a drug formulation company that has pioneered the Dispersome technology for improving the solubility and bioavailability of small molecule drugs.